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ABSTRACT 
BACKGROUND 
Bone tumours and tumour-like lesions are rare. However, they cause significant 
morbidity and mortality. Histopathological examination of bone tumours is 
considered to be a challenging field in pathology and final diagnosis should be 
given only after review of clinical and radiological findings. FNAC (Fine 
Needle Aspiration Cytology) evaluation of bone tumours is a safe, simple and 
cost-effective procedure that is minimally disruptive to bone. In this era of neo-
adjuvant chemotherapy and limb salvage surgeries, FNAC is proving to be a 
valuable tool in preliminary diagnosis of bone tumours. This study aims at 
elaborating the various bone tumours and analysing the age and gender  
distribution of these tumours. The agreement between clinico-radiological and 
histopathological diagnosis of  bone tumours has been studied. An attempt has 
been made to study the FNAC findings of bone tumours. Immunohistochemical 
markers have been used to confirm diagnosis in challenging bone tumours. 
METHODS 
The study was carried out in the Department Of Pathology, Madurai Medical 
College, Madurai, during the period from May 2012 to July 2014 on 90 
specimens of bone tumours and tumour-like lesions received in the department 
after exclusion of specimens with leukaemic infiltration of marrow. After 
adequate fixation and decalcification, representative bits were taken, processed 
and stained with Haematoxlyin and Eosin. The cases were classified based on 
WHO classification ,2002. Cohen’s Kappa value was calculated to test the 
strength of agreement between clinico-radiological and histopathological 
diagnosis. FNAC was performed on 15 bone tumours and slides stained with 
H&E after fixation. The observations were compared with other studies and 
inferences drawn. The provisional histopathological diagnosis of two bone 
tumours was confirmed by immunohistochemical markers. 
RESULTS 
Bone tumours and tumour-like lesions formed only 1.03% of all diagnosed 
neoplasms received in the department during the study period. Benign bone 
tumours formed 58.9% of the study material and 36.7% were malignant bone 
tumours. Among the malignant tumours, 66.7% were primary bone 
malignancies and 33.3% cases were metastatic deposits. Cartilage tumours 
formed the major category constituting 43.3%. Osteosarcoma was the most 
common primary bone malignancy (50%) while osteochondroma was the 
commonest benign tumour (66%). The incidence of tumours was maximum 
during second decade of life (45.6%). Osteosarcoma and osteoid osteoma 
showed predilection for males.  Bone tumours were most commonly 
encountered around the knee joint (23.3%). Metastasis occurred most commonly 
in the femur (36.4%). 85 cases showed agreement between clinicoradiological 
and histopathological diagnosis. In 5 cases,  the histopathological diagnosis was 
not in agreement with clinicoradiological diagnosis. Cohen’s Kappa value was 
0.943 which showed excellent agreement between clinicoradiological and 
histopathological diagnosis.  
Out of the 12 adequate FNAC smears, categorisation was correctly done in 10 
cases. However, in 2 cases of suspected osteosarcoma, a cytological diagnosis of 
sarcoma, not otherwise specified was given due to lack of osteiod. These two 
cases were later confirmed by histopathology to be osteosarcoma. 
IHC was used to confirm a provisional histopathological diagnosis of primary 
bone lymphoma using CD 45 immunostain. Also, a provisional 
histopathological diagnosis of metastatic deposits of follicular thyroid carcinoma 
to skull with occult primary was confirmed by TTF -1 and Thyroglobulin 
immunomarkers. 
CONCLUSION 
There is very good agreement between clinico – radiological and 
histopathological diagnosis in bone tumours. However, many benign bone 
tumours and tumour - like lesions mimic malignant lesions radiologically. 
Hence, histopathological confirmation of radiological diagnosis should always 
be done before definitive treatment. A close co – ordination between the 
orthopaedician, radiologist and pathologist is the best approach to treat a patient 
with bone tumours. 
Cytology can serve as a good tool for rendering quick and cost effective 
diagnosis for further management. However, the results of FNAC should be 
cautiously interpreted and when in doubt, histopathological confirmation should 
be obtained before treatment.  
Immunohistochemistry has its own role in bone tumour diagnosis. It can be a 
valuable tool in categorising small round cell tumours and determining sites of 
occult primary in case of metastasis to bone. 
KEY WORDS 
Bone tumours, tumour-like lesions, osteosarcoma, FNAC (Fine Needle 
Aspiration Cytology), Radiology, Immunohistochemistry. 
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INTRODUCTION 
 
 Bone is a highly specialized connective tissue engineered by nature to 
perform a variety of important functions. Bones and joints together provide the 
stability needed for movement, protect internal organs and determine a person’s 
build and stature. This dynamic tissue is essential for mineral homeostasis and 
also houses the blood forming bone marrow. 
 Primary tumours of the bone are rare
1
. They account for less than one 
percent of the overall human tumour burden. The morbidity and mortality 
associated with them is however, very significant. Bone tumours are diverse in 
their gross and morphologic features. They may present as relatively benign 
lesions of no clinical significance to highly aggressive and rapidly fatal tumours. 
Every age group is affected but the peak incidence
2
 usually occurs in the second 
decade of life. Diagnosis should be made at the earliest and appropriate therapy 
instituted rapidly so that affected patients enjoy a good quality of life in this era 
of limb salvage surgeries. 
 Bone tumours often pose diagnostic challenges. Low incidence of these 
tumours and the resulting limited experience in dealing with them adds to the 
diagnostic difficulties. The key to their accurate diagnosis is utilization of an 
integrated approach
3
 involving clinical, radiological and histopathological 
findings. 
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Fine Needle Aspiration Cytology (FNAC) is turning out to be a useful 
alternative to open biopsies in diagnosis of bone lesions. It is safe, simple, 
highly economical and a relatively painless procedure which can be performed 
at the bedside or in the out- patient department. It has the advantage over biopsy 
of being less disruptive
4
 to bone, permitting multiple sampling and leaving no 
scar. With the development of neo-adjuvant chemotherapy and new orthopaedic 
surgical techniques like limb salvage procedures, there has been an enhancement 
in the role of FNAC in management of metastatic as well as primary malignant 
bone tumours. 
 Immunohistochemical study for the diagnosis of bone tumors has to be 
scheduled after an appropriate analysis of clinical data, radiological findings and 
results of histological sections. Immunohistochemistry (IHC) plays a significant 
role in accurate diagnosis of certain groups of bone tumours. Small cell 
osteosarcomas may be confused with other small round cell tumours
5
 and here, 
IHC may serve as the deciding factor. Metastatic tumours can also be 
categorized by IHC. 
 This study aims at elaborating the wide range of bone tumours and 
tumour-like lesions. The agreement between clinico - radiological and 
histopathological diagnosis has been studied in detail. An attempt has been made 
to study the FNAC findings of bone tumours.  Immunohistochemical markers 
have been used to diagnose challenging bone tumours. 
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AIM OF THE STUDY 
1. To study the distribution of various bone tumours and tumour - like 
lesions during the period from May 2012 to July 2014. 
2. To analyse the age and sex distribution of bone tumours and tumour - like 
lesions. 
3. To elaborate the spectrum of bone tumours and tumour – like lesions by 
histopathological examination. 
4. To establish the statistical significance by testing the strength of 
agreement between histopathological and clinico-radiological diagnosis 
by Cohen’s kappa value. 
5. To study the FNAC (Fine Needle Aspiration Cytology) findings of 
selected bone tumours. 
6. To study the usefulness of immunohistochemical markers in categorising 
diagnostically challenging bone tumours. 
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REVIEW OF LITERATURE 
EMBRYOLOGY 
 The skeletal system develops from paraxial mesoderm
6
, lateral plate 
(parietal layer) mesoderm and neural crest. Paraxial mesoderm forms somites. 
The ventromedial part of somites called sclerotome gives rise to the connective 
tissue of the embryo called mesenchyme. These mesenchymal
7
 cells migrate and 
differentiate to form fibroblasts, chondroblasts and osteoblasts. 
  The parietal layer of lateral plate mesoderm forms bones of pelvic and 
shoulder girdles, limbs and sternum. Neural crest cells also differentiate into 
mesenchyme and in the region of head, participate in the formation of skull and 
facial bones.  Bones of the cranial vault and base of skull are also formed from 
occipital somites and somitomeres.  
 If mesenchyme differentiates directly into bone, the process is called 
intramembranous
8
 ossification (Fig.1). Flat bones of the skull may develop in 
this manner. In most other bones, mesenchymal cells first form cartilage models 
that ossify later, a process called enchondral ossification.  
MACROSCOPIC ANATOMY OF BONE (Fig.2) 
 Human skeletal system has 206 bones. The skeleton is divided into two 
regions: the axial skeleton (skull, vertebrae, ribs, sternum, hyoid) and the 
peripheral skeleton (the limbs and pelvis). 
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Living bone is white. The texture of compact bone is dense like ivory 
and that of cancellous or spongy bone is honeycombed. The hard thin outer 
shell is called compact bone or cortex. The marrow cavity is housed inside the 
cortex and contains hematopoietic elements, fat and spicules of bone called 
trabecular or spongy bone. 
 Based on their general shape, bones are classified as long, short, flat, 
irregular and sesamoid bones. 
 Topographically, long bone is divided into three regions: diaphysis, 
epiphysis and metaphysis. Diaphysis is the shaft; epiphysis is the region at the 
ends of the bone and is partially covered by articular cartilage. At the junction of 
epiphysis and diaphysis lies the metaphysis. It is the epicentre for many bone 
tumours. Epiphyseal plate is seen occupying the junction of metaphysis and 
epiphysis in growing bones. Enchondral ossification occurs at the epiphyseal 
plate. When the bone has reached its adult length, the epiphysis closes by 
becoming completely ossified. The epiphyseal plate is considered of paramount 
importance in bone pathology because it is by far the commonest site of 
occurrence of most primary bone tumours. 
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Fig.1 – Development of bone 
 
 
Fig. 2 – Macroscopic anatomy of Long Bone 
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Short bones are roughly cuboidal in shape. They are chiefly composed of 
cancellous bone with a thin cortical shell. Examples of short bones are scaphoid, 
lunate, talus and calcaneum – bones of hand and foot. 
 Flat bones consist of thin inner and outer layers of compact bone, the 
tables . The tables are separated by a layer of cancellous bone, the diploe. Bones 
of the vault of the skull , frontal and parietal bones and scapula are examples of 
flat bones. 
 In long and short bones, bone marrow occupies the marrow cavity. In flat 
and irregular bones, the interstices of cancellous bone contain bone marrow. The 
marrow can be red haematopoietic or of yellow adipose type according to the 
age and site. 
 Periosteum and endosteum are fibrous layers that line the external and 
internal surfaces of bone respectively.  
Vascular supply
9
 –  
 The shaft of long bones is penetrated by diaphyseal nutrient arteries. 
They enter the shaft obliquely through nutrient foramina that lead to nutrient 
canals. Nutrient arteries divide into ascending and descending branches in the 
medullary cavity. Metaphyseal arteries are direct branches of neighbouring 
systemic vessels. Epiphyseal arteries are derived as branches from vascular 
plexus formed on non – articular surfaces of bone. 
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Innervation – 
Richly innervated structures of the skeletal system include 
- Periosteum 
- Articular extremities of long bones, vertebrae and larger flat bones 
The perivascular spaces of haversian canals contain axons which accompany 
nutrient vessels into bone marrow. 
 HISTOLOGY 
The microscopic examination of bone dates back to the earliest days of 
microscopy. Full and accurate descriptions of all human bones have been 
elucidated in classical books like Osteologia Nova
10
 and Osteographia. 
Bone is composed of an extracellular mineralised matrix and different 
types of cells including osteoblasts, osteocytes, osteoclasts, marrow and 
components of the periosteum and endosteum. 
Bone matrix consists of a ground substance with embedded collagen 
(Fig.3) fibres. The ground substance is composed of glycosaminoglycans, 
proteoglycans and water. Osteocalcin and osteonectin are two special 
glycoproteins present in large quantities. The inorganic ions present are chiefly 
calcium and phosphorus. They are present as needle shaped crystals of 
hydroxyapatite (Ca10[PO4]6[OH]2). 
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Fig. 3 – Composition of Bone 
 
 Osteoblasts (Fig. 4)   lay down organic matrix of bone including collagen 
and are also responsible for calcification of the matrix. They have basophilic 
cytoplasm and ovoid euchromatic nucleus. Cytoplasmic basophilia is due to 
abundant rough endoplasmic reticulum. Osteocytes (Fig. 4)   are formed when 
osteoblasts become imprisoned in the matrix during bone formation. In contrast 
to osteoblasts, osteocytes have eosinophilic cytoplasm due to negligible 
secretory activity and less endoplasmic reticulum. Osteoclasts (Fig. 5)    arise 
from mononuclear macrophage precursors and are large cells 20 – 100 
micrometer in diameter located in resorption bays called lacunae of Howship. 
They have numerous nuclei and their chief function is bone resorption. 
10 
 
 
Fig. 4 – Osteoblasts and Osteocytes 
 
 
Fig. 5 - Osteoclast in a Howship’s lacuna. Goldner stain. 
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The junction between the original resorbed surface and new bone is called 
cement line. It is sharp and basophilic with routine staining. 
 Lamellar bone that makes up almost the entire osseous skeleton is 
organised concentrically as cylinders around neurovascular channels 
(Haversian canals). Volkmann’s canals10 are vascular channels connecting 
Haversian canals to each other and to vessels in the periosteum. 
The periosteum has two layers - the outer fibrous layer , the inner cellular layer. 
 In young bones, the inner cellular layer has numerous osteoblasts whereas 
osteoprogenitor cells are present in the cellular layer in adults. Numerous nerve 
fibres are present in the periosteum. Perforating collagen fibres called 
Sharpey’s fibres attach the periosteum to the surface of the bone. Neoplastic 
processes or physical tearing forces may detach the periosteum from the bone 
cortex due to damage to sharpey’s fibres. New bone formation that occurs 
between the raised periosteum and cortical layer of bone may lead to 
radiological changes. 
CLINICO-RADIOLOGICAL EVALUATION 
CLINICAL ASPECTS 
A detailed history and thorough physical examination are a pre - requisite 
for diagnosing bone tumours. Patients may present with a wide range of 
symptoms that do not prompt the clinician to a correct diagnosis.  
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Pain, swelling, limitation of movement and fracture on trivial trauma are 
the commonest presenting symptoms. 
Pain – The first symptom of nearly all malignant bone tumours is pain11. It 
begins as a tearing neuralgia like pain which later becomes constant and 
gnawing. As the disease progresses, the pain may become agonizing requiring 
treatment with opiates. A tumour impinging on nerve trunks may cause radiating 
pain. 
Swelling – Swelling is the next significant symptom in bone tumours. In benign 
neoplasms, the patient may be living with the swelling for many years. For a 
bone tumour to present as swelling, it should either have an extra - osseous 
component or the tumour should expand the bone.  
Rapidly developing swellings are usually malignant.  Tumours may be 
bony hard or have soft areas. The consistency of the tumour ought to be noted. 
Secondary changes in skin like stretching of skin with prominent veins, warmth 
and denudation of overlying epithelium may occur.  An assessment of mobility 
of skin and subcutaneous tissue overlying the tumour should be made. 
Malignant lesions present with lesser mobility of underlying structures due to 
rapid growth of tumours. 
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Limitation of movement – Lesions close to the joint may cause limitation of 
mobility. This is seen with osteoblastomas, chondroblastomas, giant cell 
tumours and sarcomas. 
Pathological fracture – Fracture may occur with no prior symptoms as in 
juvenile cysts and non-ossifying fibromas. Metastatic osteolytic lesions are 
usually associated with pathological fractures. Less common is the likelihood of 
primary bone tumours presenting with fractures. 
General symptoms – Fever and loss of weight and appetite are symptoms 
associated with malignant tumours.  
Fig.6 depicts the site predilection of bone tumours. 
Fig.7 shows common lesions affecting different bones.  
Table 1. shows the peak age predilection of bone tumours. 
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Fig6. – Site predilection of bone lesions 
 
Fig7.  Common lesions affecting different bones 
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Table 1 - Peak age predilection of bone lesions
14 
Age(yr) Benign Malignant 
 
 
 
 
 
 
<20 
 
 Enchondroma 
 Chondromyxoid fibroma 
 Chondroblastoma 
 Osteoid osteoma 
 Osteoblastoma 
 Langerhans cell 
histiocytosis 
 ABC 
 Simple bone cyst 
 Fibrous dysplasia 
 Osteofibrous dysplasia 
 
 Leukemia  
 Ewing sarcoma 
 Osteosarcoma (conventional, 
telangiectatic) 
 Metastatic disease from 
Neuroblastoma, 
Retinoblastoma, 
Rhabdomyosarcoma and 
Hodgkin lymphoma 
 
 
20-40 
 
 Enchondroma 
 Chondromyxoid fibroma 
 Osteoblastoma 
 Osteoid osteoma 
 GCT 
 Fibrous Dysplasia 
 
 
 Osteosarcoma (parosteal) 
 Adamantinoma 
 
 
 
 
>40 
 
 Chondrosarcoma 
 Osteosarcoma secondary 
to Paget disease 
 MFH 
 Lymphoma 
 Fibrous dysplasia 
 Metastatic disease 
 Myeloma 
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RADIOLOGICAL ASPECTS 
 Conventional radiographs are considered a gold standard for initial 
assessment of suspected bone lesions
12
. They provide most crucial information 
about the nature, progression, location and aggressiveness of bone lesions. The 
CT scan is an effective tool in visualising the anatomical location of the tumour, 
disruption of overlying cortex and calcifications within the tumour. MRI
13
 helps 
in demonstrating abnormalities of bone marrow and illustrating soft tissue 
reactions to cancerous growths. Bone scintigraphy is a highly sensitive 
technique in detection of suspected bone metastases in the skeleton. 
 The following points are to be considered while reading an x-ray -  age, 
location ( type of bone, cortex/medulla, epiphysis/ metaphysis/ diaphysis), 
unifocal/multifocal, margins, periosteal reaction, matrix calcification, soft tissue 
shadows and fracture. 
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In order to reach a correct diagnosis, following specific signs must be 
considered – 
 1. Patterns of bone destruction (Table 2) and configuration of margin. 
 2. Penetration of cortex. 
 3. Presence of sclerotic rim. 
 4. Presence and extent of expanded cortical shell. 
Table 2: Patterns of bone destruction
15 
 
Type I 
 
 
Geographic pattern 
  
 
IA 
 
 
Normal area separated from lytic regions by a sclerotic rim. 
  
IB 
 
 
Absence of sclerosis. Lesion is well limited with distinct separation from normal 
bone. 
 
 
IC 
 
 
Less sharp limit between the normal and lytic area 
  
Type II 
 
 
Moth-eaten pattern. Multiple lytic areas separated by bone not yet destroyed 
denotes aggressive pattern of tumour progression 
  
Type III 
 
 
Permeative pattern. A lesion growing aggressively and rapidly presents with a 
blurring or fuzzy transition. 
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The patterns of bone destruction have been depicted in Fig. 8. 
 
 
  
 
 
 
 Type 1     Type 2     Type 3 
Fig. 8 Patterns of bone destruction 
 Matrix mineralisation (Fig.9) can affect radiographic opacity of a lesion. 
Matrix refers to type of tumour tissue like osteoid, chondral or fibrous. 
Calcification of matrix is called mineralisation. Uncalcified matrix is 
radiolucent.  
Calcification of chondral tissue may produce the following types of 
mineralization – 
 1. Punctate / stippled 
 2. Flocculent 
 3. Arc / ring like 
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Bone forming tumours produce fluffy, amorphous or cloud like mineralization. 
This may cause different types of radiographic appearance – 
 4. Solid 
 5. Cloud 
 6. Ivory 
       1.        2.          3. 
 
 
 
 
 
 
        4.    5.          6.  
Fig. 9 Matrix mineralisation 
Periosteal reaction
15
 is an important radiographic feature that helps characterise 
a bone lesion (Fig.10). 
1. Solid or unilamellated periosteal reaction is a non aggressive appearance. 
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2. Multilamellated or ‘onion skin’ appearance is suggestive of an intermediate  
    aggressive process. 
3. Spiculated , ‘hair on end’ or ‘sunburst’ pattern is a very aggressive 
    appearance highly suggestive of malignancy.                         
4. Codman triangle refers to elevation of periosteum away from the cortex.  
An angle is formed  at the meeting point of elevated periosteum with the bone. 
 
Fig. 10 Periosteal reaction 
If cortex is disrupted and soft tissues are involved, it usually indicates that the 
tumour is aggressive. 
 Cortical destruction may be of “ballooning” type. The endosteal cortical 
bone is destroyed and there is simultaneous laying down of new bone on the 
outside. This results in ballooning of the affected area and formation of a 
neocortex.  
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This ‘neocortex’ can be smooth and uninterrupted, but in more aggressive 
lesions like GCT, it may be focally interrupted. 
The following tumours may show multiple lesions – chondromas, 
osteochondromas, Langerhans cell histiocytosis and metastases. 
 Osteolytic lesions can be classified as well defined or ill – defined by 
looking at the zone of transition between it and the adjacent normal bone. A 
small zone of transition results in a sharp, well – defined border and is a sign of 
slow growth. An ill – defined border with broad zone of transition is indicative 
of aggressive growth. Infections may mimic malignancy due to aggressive 
growth patterns. 
Radiological picture of  metastatic bone tumours
16
 –  
 Predominantly lytic – Lung, Kidney, Melanoma, Colon. 
 Predominantly blastic – Prostate, Breast. 
 Mixed lytic and blastic  - This is the commonest appearance. 
PATHOLOGY 
The WHO classification of Bone tumours ( 2002) has been given in  
Annexure I. 
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CARTILAGE TUMOURS 
OSTEOCHONDROMA 
Osteochondroma accounts for around 35% of benign bone tumours. It is the 
most frequently encountered benign tumour. The tumour occurs predominantly 
in the first two decades of life. Rare cases in infants and newborns
17
 have been 
reported. Osteochondromas have an osseous stalk capped by cartilage. The stalk 
is in continuation with the underlying bone.  
Though majority of these tumours (85%) are solitary
18
, 15% of them arise in a 
setting of hereditary multiple exostoses, an autosomal dominant disorder. Germ 
line mutations in tumour suppressor genes EXT 1 or EXT 2 are found in 90% of 
patients with hereditary multiple exostoses. The EXT 1 and EXT 2 proteins are 
important in the biosynthesis of heparin sulphate proteoglycans which are 
multifunctional proteins involved in several growth signalling pathways in the 
normal epiphyseal growth plate. Reduced expression of these proteins in 
osteochondromas is associated with disordered cellular distribution of these 
proteoglycans. Defective enchondral ossification that ensues, leads to formation 
of osteochondromas. 
The tumour grows in size as the patient grows. Once epiphyses close, it  
becomes quiescent. Rarely, radiation therapy in children has led to the 
development of osteochondromas. Chondrosarcomatous change occurs in less 
than 1% of patients with multiple hereditary exostoses.  
23 
 
Patients maybe asymptomatic and present with a long standing painless mass 
that may either be ignored by the patient or be of cosmetic significance. If the 
tumour impinges on a nearby nerve, it may lead to pain. Cases have been 
reported where bursae form over an osteochondroma leading to pain. 
Infrequently, the stalk of the lesion may become infracted or fractured. An 
overlying vessel may show pseudoaneurysm formation due to pressure. 
However, increasing pain is an indication of malignant transformation and 
should be considered seriously. 
 Lower end of femur and upper end of tibia are the commonest sites of 
occurrence, though flat bones, ileum and scapulae may be involved in 5% of 
cases. 
Radiologically (Fig.13,14) , the lesion may be sessile or pedunculated. 
Osteochondromas appear as a protruberance from the bone shaft in a juxta-
epiphyseal location and are contiguous with the adjacent cortical bone. The 
lesion usually points away from the adjacent joint. Irregular calcification is often 
seen. Excessive cartilage type fluffy calcification is an indication of malignant 
process. 
On macroscopic examination (Fig.12) , the lesion is usually an irregular bony 
mass with a bluish-gray cartilaginous cap. The lesion has a rim of cortical bone 
in its base  and central cancellous bone which is in continuation with the shaft. 
The cap varies in thickness. A thick (> 2 cm) or irregular cap may be suggestive 
of malignancy.
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On histopathology (Fig.15), the tumour has three layers - perichondrium, 
cartilage and bone. The chondrocytes within the cartilage cap are clustered 
superficially, and towards the transition zone, they resemble the growth plate. 
Organisation into chords and enchondral ossification occurs. 
CHONDROMAS 
Chondromas are benign cartilaginous neoplasms that can be centrally located in 
the bone (enchondromas) or eccentric (periosteal chondroma). This group of 
tumours shares many histologic features. Chondromas usually occur 
sporadically but enchondromatosis ( Ollier’s disease ) usually manifests as a 
congenital tumour syndrome. 
ENCHONDROMA 
They are relatively common benign intramedullary cartilaginous neoplasms 
which most often occur in the short tubular bones
19
 of hands and feet of adults. 
The lesions are usually asymptomatic. An enlarging lesion may fracture and 
cause pain.  
Radiologically, they produce a localised central region of rarefaction. Unless a 
fracture has occurred, the cortex is intact. Calcification may appear as fine, 
punctate stippling. 
Gross examination reveals bluish grey lobules of firm translucent tissue. 
Microscopically (Fig.16), enchondromas show minute chondrocytes placed in 
lacunae. The nuclei are round and not well delineated in low power examination. 
Lesions of small bones differ from those in large bone by: 
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- Increase in cellularity. 
- Clustering of chondrocytes. 
- Some amount of myxoid change. 
- Increase in nuclear size. 
- Binucleation. 
However, if cortex is breached or bone is entrapped, it is suggestive of 
chondrosarcoma.  
JUXTACORTICAL (PERIOSTEAL) CHONDROMA 
This tumour is located on the metaphyseal cortex. On imaging studies, a 
scalloped cortical defect with a sclerotic margin is seen. Typically, the lesion has 
overhanging edges. Juxtacortical chondroma is a periosteum covered, well – 
circumscribed lesion partially embedded in cortical bone. On cut surface, it is 
greyish white, or bluish and lobulated. Proliferating chondrocytes showing 
minimal pleomorphism and nuclear abnormalities are seen on microscopic 
examination. Limited extension into adjacent cortex may be seen. Penetration 
through cortex into medullary cavity however suggests a juxtacortical 
chondrosarcoma. The tumour is treated by enbloc resection. 
ENCHONDROMATOSIS (OLLIER’S DISEASE) 
This developmental disorder was discovered by the father of French orthopaedic 
surgery – Louis Xavier Edouard Leopold (Ollier). 
 
 
26 
 
It is caused by failure of normal enchondral ossification. Multiple cartilaginous 
masses are seen in the metaphysis and nearby areas of shafts and flat bones 
during childhood.  Predominantly unilateral involvement is seen along with 
bone deformity. Some studies have implicated a gene encoding for a receptor of 
parathyroid hormone (PTH) and PTH-related peptide (PTHR1)
20
 to be 
associated with Ollier disease. 
When Ollier disease is associated with soft tissue angiomas, it is called 
Maffucci’s syndrome. 
Chondrosarcoma may develop in 25% of patients by forty years of age in Ollier 
disease . In Maffuci’s syndrome, the risk of malignant transformation is even 
higher. 
CHONDROBLASTOMA 
This is a benign tumour that originates from cartilage and shows predilection for 
the epiphyseal region. It occurs mostly in patients under 25 years of age. Around 
one-fourth of cases in long bones reported by Kurt
21
 and associates involved an 
apophysis, either greater trochanter of femur or the greater tuberosity of the 
humerus. The presenting complaint usually is pain, sometimes longstanding. 
Rare lesions can metastasize. They are probably passively transported to the 
lung as surgical removal of the metastatic lesions gives complete cure. 
Radiologically, the lesion is lytic. Margins however are well defined and 
sclerotic. The lesion is centered in the epiphysis.  
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In a case series reported by Kurt
21
 and associates, 97 % of chondroblastomas of 
long bone were either entirely epiphyseal or had an epiphyseal component. 
Majority of cases do not show matrix production. The lesion may secondarily 
degenerate into an aneurysmal bone cyst. On macroscopic examination, these 
lesions are circumscribed and variegated with blue gray areas representing 
cartilaginous regions and chalky gritty areas representing calcified zones. 
Microscopically, a variety of histopathological appearances may be seen due to 
variations in matrix and cell types. The basic proliferating cell is said to be a 
chondroblast. It is oval in shape with distinct cytoplasmic borders. The nucleus 
is oval and has a longitudinal groove in the middle that gives rise to a coffee-
bean appearance. Osteoclasts are unevenly distributed in the sections and 
chondroid material is seen in the background. Chicken wire calcification is 
seen in many cases. Brown granular pigment, positive with iron stain is present 
in approximately one-fourth of all cases. These pigments are commonly seen in 
tumours of skull bones and may indeed be very prominent. 
 The treatment consists of simple curettage with or without bone grafting. In a 
case series reported by Turcotte
22
 and co-authors, 9 out of 64 patients treated 
with curettage had recurrence 
CHONDROMYXOID FIBROMA 
An infrequently occurring benign bone tumour, chondromyxoid fibroma occurs 
in patients mostly in their twenties or thirties.  
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It occurs eccentrically in the metaphysis of lower femur or upper tibia or in short 
tubular bones of foot. 
Radiography shows an eccentric, well – demarcated lucent defect with a thin, 
well – defined scalloped border of sclerotic bone.  
Gross examination of the intact specimen shows a well demarcated lesion 
covered by a thin rim of bone or periosteum. On cut surface, it appears as a firm, 
lobulated, grayish white mass. Small cystic foci and haemorrhage may be seen. 
A lobulated pattern with sparsely cellular lobules alternating with more cellular 
zones is seen on microscopy (Fig. 17). Spindle and stellate cells without distinct 
cytoplasmic borders are seen in the sparsely cellular lobules. They are arranged 
in a myxoid matrix. Running between these lobules are highly cellular fibrous 
septae with scattered multinucleated giant cells. As recurrences are common 
after curettage, enbloc excision is done. 
CHONDROSARCOMA 
Chondrosarcoma is a malignant neoplasm in which tumour cells form chondroid  
matrix.  Osteoid production is not a feature of this tumour. Adults in their fifth 
and sixth decades are most commonly affected. The most frequent sites are 
pelvis, the medullary cavity of femur, humerus and ribs. Persistent mild   pain 
and local swelling are the initial complaints.  
The tumour is classified into primary or secondary based on whether it arises de 
novo from normal bone or develops by malignant transformation in 
osteochondromas and enchondromas. 
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PRIMARY CHONDROSARCOMA 
Primary chondrosarcoma accounts for one fifth of all malignant bone tumours. 
Among all primary bone tumours, it is the third most frequent tumour. The 
tumour arises centrally in a previously normal bone. 
The radiograph is nearly always helpful and often affords almost 
pathognomonic evidence of chondrosarcoma. Chondrosarcomas tend to be large. 
In a study by Bjornsson
23
 and co-workers, the mean size of the tumours of the 
180 cases for which radiographs were available was 9.5cm. In long bones, the 
tumour presents as a metaphyseal or diaphyseal fusiform expansion. Cortex is 
many a times thickened. Radiolucent areas with ring like opacities are seen. The 
tumour shows minimal periosteal reaction. 
Macroscopically (Fig.20), the tumour is translucent and blue grey due to 
presence of hyaline cartilage. Lobular growth pattern may be apparent with 
cystic, myxoid and chalky white areas. Cortical erosion with soft tissue 
extension is seen more commonly in tumours of flat bones. 
 Microscopically (Fig.21&22), blue gray cartilage matrix production is evident 
at low magnification. Lobules of cartilage of varying shapes and sizes are seen 
either separated by fibrous bands or permeating bony trabeculae. 
The criteria that differentiate low –grade chondrosarcoma from chondroma are 
very subtle. Mirra
24
 and co-authors proposed several histologic criteria to make 
this distinction.  
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Enchondromas tend to form well-circumscribed nodules that may be surrounded 
by bony trabeculae. Chondrosarcomas tend to permeate, filling the marrow 
cavity and entrapping bony trabeculae. This permeative quality is the most 
important feature distinguishing chondrosarcoma from enchondromas (Fig.18). 
Chondromas tend to have a solid chondroid matrix. The matrix stains blue and 
has a smooth, unbroken appearance under low power. Chondrosarcomas  tend to 
show a myxoid change in the matrix. This manifest as partial dissolution of 
matrix into strings and chords. Foci of necrosis manifesting as lacunae 
containing pink-staining cells without blue-staining nuclei is a worrisome 
feature.  
As a rule, cartilaginous tumours of the sternum are malignant. The features 
suggested by Lichtenstein and Jaffe
25
 are very helpful to diagnose 
chondrosarcoma when viable fields are studied. These include many cells with 
plump nuclei, more than occasional cell with two such nuclei, and especially, 
giant cells with large nuclei or multiple nuclei or clumps of chromatin. 
Grading predicts histologic behaviour and prognosis in chondrosarcoma. They 
are graded mainly based on cellularity of neoplasm and cytologic atypia. 
Mitotic activity being uncommon, is not used in grading chondrosarcomas. 
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Table – 3 GRADING OF CHONDROSARCOMAS26 
Grade 1 
 
More cellular than enchondromas; nuclei small; high chromatin 
density. 
 
Grade 2 
Cellularity increased; medium sized regular nuclei; loose chromatin 
structure. 
 
Grade 3 
Extreme cellularity; large bizarre nuclei; binucleate forms; small foci 
of spindling at the periphery of the lobule. 
  
SECONDARY CHONDROSARCOMA 
This tumour is marked by the occurrence of chondrosarcoma in a benign lesion 
like osteochondroma or enchondroma. There is 2% risk of malignant 
transformation in osteochondromas. Patients with Ollier disease and Maffucci 
syndrome have a 25-30 % risk of developing chondrosarcoma. Patients 
frequently present with sudden pain or increase in size of the swelling. 
Roentgenogram shows irregular mineralisation and thicker cartilage cap as 
evidence of malignant transformation in osteochondromas. Destructive 
permeation of bone and appearance of soft tissue mass suggest malignancy in a 
chondroma. Macroscopic appearance of a greater than 2cm cartilage cap 
thickness with lobulations and cystic cavities may be suggestive of malignant 
transformation.  
Microscopically, secondary chondrosarcomas are usually low grade tumours 
invading the surrounding tissues and showing marked myxoid change in matrix. 
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DEDIFFERENTIATED CHONDROSARCOMA 
This is a term used for lesions in which a high-grade, non-chondromatous 
sarcoma (Osteosarcoma, Malignant fibrous histiocytoma, Rhabdomyosarcoma) 
arises in a patient harbouring a benign cartilage neoplasm. Majority of patients 
are of elderly age group in their fifth decade of life. The distribution of these 
tumours parallels that of conventional chondrosarcomas. 
On imaging, these tumours are usually large and show aggressive, destructive 
changes. Characteristically, the lesions have a bimorphic pattern, with an area of 
low-grade tumour juxtaposed to an area of more aggressive destructive change. 
Grossly and microscopically, the tumour shows areas representing the 
chondrosarcoma and the other sarcoma component. In three fourths of cases, the 
chondrosarcoma component is of grade 1. The tumour has to be differentiated 
from chondroblastic osteosarcoma. The cartilage cells are of high grade in 
chondroblastic osteosarcoma. 
MESENCHYMAL CHONDROSARCOMA 
This is an uncommon malignant neoplasm seen most commonly in patients in 
their twenties and thirties. The tumour shows a predilection for maxilla, 
mandible and ribs though any bone may be affected. 
The characteristic microscopic feature of this tumour is its biphasic pattern. 
Small, uniform, round to spindle shaped cells showing perivascular arrangement 
resulting  in hemangiopericytoma - like pattern are seen.  
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Focal areas of cartilaginous or chondroid matrix are seen admixed in lobular 
pattern with the cellular areas. This tumour predominantly metastasizes to lungs. 
CLEAR CELL CHONDROSARCOMA 
This is a rare malignant, slow growing tumour composed of malignant 
chondrocytes having abundant clear cytoplasm. Males are affected more 
commonly. Patients are usually in their third or fourth decade of life. 
Radiologically, the tumour is well circumscribed and shows mixed lucent and 
sclerotic defects with a thin sclerotic border and scattered calcifications. 
Microscopically, the tumour cells have abundant clear, vacuolated cytoplasm 
containing PAS positive glycogen seen infiltrating woven bone and lying 
between heavily calcified cartilage matrix. The giant cells and chondroid matrix 
help to differentiate it from metastatic renal cell carcinoma. 
FNAC in chondrosarcoma shows –  
- Predominantly tissue fragments in low-grade (grades 1 and 2) tumours. 
Single cells may dominate in high grade sarcomas. 
- Abundant eosinophilic vacuolated cytoplasm. 
- Chondromyxoid material. 
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OSTEOGENIC TUMOURS 
OSTEOID OSTEOMA 
These are relatively common, solitary, benign, small (less than 1 cm in 
diameter) lesions. Children and adolescents are most commonly affected and 
boys are affected twice as commonly as girls. 
Nocturnal pain which is usually relieved by aspirin is the most characteristic 
clinical presentation. Local swelling, tenderness and leukocytosis may be 
present.  
The typical site of involvement is the cortex of a long bone. Radiology (Fig.23) 
shows a central lucent zone (nidus), with the surrounding bone showing 
sclerosis and marked periosteal new bone formation. 
Localization of the lesion at surgery is difficult and may be aided by 
preoperative technetium (
99
Tc) isotope injection. The overlying cortical bone 
may get a pinkish hue due to periosteal reaction and increased vascularity. 
Microscopically (Fig.25), these tumours are characterised by a maze of small 
spicules of immature bone. They are lined by prominent osteoblasts and there 
are many osteoclasts. Intervening stroma is sparsely cellular with many vascular 
spaces in mature lesions. 
OSTEOBLASTOMA 
This tumour has been called as giant osteoid osteoma.  The tumour most often 
affects males in their third decade. Pain, often progressive, is the most frequent 
complaint.  
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Yoshikawa
27
 and co-authors reported two examples of osteoblastoma associated 
with osteomalacia. Mirra
28
 and co-authors described a case of osteoblastoma 
associated with severe systemic toxicity. Axial skeleton is preferentially 
involved with the posterior elements of spine being commonly affected. The 
radiographic features of osteoblastoma are often nonspecific. In reviewing the 
radiographs of 116 cases of appendicular osteoblastomas, Lucas
29
 and co- 
authors found that 65% of the tumours were located within the cortex and other 
35% in the medullary canal. Whole gross specimens are rarely seen because the 
average lesion is removed by curettage. The lesions are reasonably well 
circumscribed. The tumour is haemorrhagic, granular and friable because of its 
vascularity and osteoid component which shows variable calcification.  On 
microscopic examination (Fig.26), a vascular spindle cell stroma with 
abundant irregular spicules of mineralised bone and osteoid are seen. 
Osteoblasts and multinucleated giant cells are readily evident on bone surfaces. 
The differentiation of osteoid osteoma and osteoblastoma is rather difficult. 
However, tissue pattern appears less regular in osteoblastoma than osteoid 
osteoma. Sometimes secondary changes like aneurysmal bone cyst and fracture 
may occur. 
OSTEOSARCOMA (OSTEOGENIC SARCOMA) 
Osteosarcoma is the commonest non haematopoietic primary malignant skeletal 
neoplasm which accounts for about 20 % of all primary malignant bone 
tumours. Malignant cells produce osteoid but the pluripotential nature of the 
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tumour cell is evident in the fibrous and cartilaginous matrix present in many of 
these tumours.  
Conventional osteosarcoma is predominantly a disease of the young occurring in 
patients under 20 years of age. When these tumours occur above the age of 40 
years, the possibility of Paget’s disease or post radiation sarcoma should always 
be considered. Males are affected more commonly. 
The most common sites of involvement are the metaphyseal part of long bones 
and nearly one half occur in the region surrounding the knee. 91% of tumours 
affect the metaphysis and about 9% affect the diaphysis. With increasing age, 
involvement of jaws, pelvis, skull and spine increase. Huvos
30
 noted that in the 
Memorial Sloan – Kettering Cancer Centre group of older patients with 
osteosarcoma, the axial skeleton was the most common site. 
A deep boring to severe pain with or without swelling (Fig.27&28) is the most 
common presenting symptom. A sudden increase in pain is attributable to 
intralesional haemorrhage. Pathological fracture may occur in 5 -10 % of 
patients. Cheng
31
 and co-authors reported a case of osteosarcoma associated 
with oncogenic osteomalacia. An increased level of alkaline phosphatase, which 
occurs in about half the patients, reflects osteoblastic activity.  
The tumour exhibits marked variation in overall radiological features     
(Fig.29 &30). It may be purely osteoblastic or osteolytic though a mixed blastic-
lytic appearance is most common. Cortical destruction and tumour extension 
into soft tissue are present.  
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Non – contiguous intramedullary skip metastases growths called may occur. 
Periosteal elevation with reactive new bone formation (Codman’s triangle)   
tends to occur. Mcleod and Berquist
32
 emphasized that although the use of plain 
radiographs is the standard means for diagnosing osteosarcoma, computed 
tomograms and magnetic resonance images are far superior in delineating the 
extent of the disease. Gillespy
33
 and co-authors also emphasised the superiority 
of magnetic resonance imaging studies for preoperative staging of osteosarcoma. 
Macroscopic appearance (Fig.19) may vary from extremely soft, fleshy 
masses through firm, fibrous tumours with foci of irregular ossification and 
various amounts of chondroid material, to a densely sclerotic type. Cortical 
disruption ith soft tissue mass are usually present. Tumour is usually centered 
around the metaphysis. 
Microscopically there is tremendous variation in the appearance of the tumour. 
Lichtenstein
34
 tersely stated the essential criteria for diagnosis as – 
1. The presence of a frankly sarcomatous stroma. 
2. The direct formation of tumour osteoid and bone by this malignant 
connective tissue. 
The sarcomatous tumour cells show high degree of anaplasia and pleomorphism. 
They may be plasmacytoid, epithelioid, oval, small cell type, clear cell type or 
spindle shaped. Malignant osteoid appears as a dense eosinophilic amorphous 
material between tumour cells. Osteoid is curvilinear with arborisation. The 
thinnest form of osteoid is called filigree osteoid (Fig.35). 
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CONVENTIONAL OSTEOSARCOMA 
Type of matrix helps to subdivide osteosarcoma into – osteoblastic (50%), 
chondroblastic (25%) and fibroblastic (25%). 
Osteoblastic osteosarcoma (Fig.35) 
The matrix predominantly is bone or osteoid. It can be thin, arborising filigree 
osteoid or thick, dense sclerotic osteoid. 
Chondroblastic osteosarcoma 
Chrondroid elements predominantly malignant hyaline cartilage are admixed 
with non – chondroid elements. 
Fibroblastic osteosarcoma (Fig.36) 
The tumour cells are spindle-shaped and may be arranged in herringbone 
pattern. Matrix production is seen only focally. Some of these tumours have a 
rich vascular pattern and may even resemble a hemangiopericytoma. 
TELANGIECTATIC OSTEOSARCOMA (Fig.37) 
Following criteria are followed for diagnosing a telangiectatic osteosarcoma: 
1) Radiography – The lesion is purely lytic. Sclerosis if appreciable 
rules out the diagnosis. 
2) Grossly, the tumour resembles a bag of blood. Flesh like or 
sclerotic appearance is not seen. 
3) Microscopically, spaces are separated by septa as in an aneurysmal 
bone cyst. The cells that line the septa are cytologically malignant. 
Osteoid production is minimal. 
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The prognosis of this tumour was considered to be very poor compared to 
conventional osteosarcoma. However, Bertoni
35
 and co-authors from Bologna, 
reporting on 41 patients with telangiectatic osteosarcoma, found no significant 
difference in prognosis. 
SMALL CELL OSTEOSARCOMA 
This is a microscopically distinct variant of osteosarcoma comprising of small 
round cells but showing at least focal osteoid production. Ewing’s sarcoma, 
mesenchymal chondrosarcoma and lymphoma should be considered in the 
differential diagnosis. Reticulin stain may be used to differentiate small cell 
osteosarcoma from Ewing sarcoma. Reticulin is seen to stain around the 
individual tumour cells in small cell osteosarcoma. However, in Ewing sarcoma 
reticulin is scant. Neoplastic osteoid is characteristically absent in Ewing 
tumour. Mesenchymal chondrosarcoma may also be considered in the 
differential diagnosis. It has a predilection for axial skeleton. Though small cells 
are seen, there is a component of low grade cartilage. Cartilage if present in 
small cell osteosarcoma, presents with malignant looking, high grade 
differentiation. Lymphoma panel of IHC markers helps to distinguish small cell 
osteosarcoma from lymphoma. 
LOW GRADE CENTRAL OSTEOSARCOMA 
This tumour usually occurs in individuals who are older than those affected by 
the conventional high grade tumours.  
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On imaging studies, the lesions may be sclerotic mimicking large bone islands 
or resemble foci of solitary fibrous dysplasia. Microscopically, these tumours 
have a fibrous stroma with bland looking foci of bone formation. They mimic 
conventional surface (parosteal) lesion or fibrous dysplasia. The clinching points 
favouring diagnosis are the identification of the invasive character of the lesion, 
typified by the presence of islands of residual lamellar bone within the lesion 
and evidence of malignant tumour bone plastered onto and surrounding these 
islands of residual bone . This tumour has a more indolent clinical progression. 
Local recurrences are however high. 
SECONDARY OSTEOSARCOMA  
These tumours occur in bones which are already affected by some pathology. 
Paget disease of bone, irradiation for a prior tumour, infarction of bone, 
prosthetic implant in the joint, and tumour like-lesions (fibrous dysplasia) are 
suggested etiologies.  
Paget osteosarcoma constitutes one fifth of all osteosarcomas in patients 
beyond the third decade of life.  Two – thirds of sarcomatous change occurs in 
large limb bones and one-third in flat bones. Skull involvement is seen in        
10-17% of all Paget osteosarcomas. Multifocal osteosarcomas may be seen in 
17% of patients with polyostotic Paget disease. Patients present with change in 
pain pattern, increase in size of swelling or pathological fracture. Elevation of 
alkaline phosphatase levels above those seen in Paget disease is usual.  
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Radiological studies reveal underlying features of Paget disease with 
superimposed tumours exhibiting lytic pattern more often than blastic or 
sclerotic appearance. Histpathologically, Paget osteosarcomas are high grade 
sarcomas mostly of osteoblastic or fibroblastic type. The prognosis for these 
patients is poor especially for those in pelvic girdle and skull. 
Post radiation osteosarcoma constitutes 3.4-5.5% of all osteosarcomas. The risk 
of osteosarcoma developing in an irradiated bone is 0.03-0.8%. The greatest risk 
of sarcoma is seen in children treated with high dose radiotherapy and 
chemotherapy. Pelvis and shoulder girdle are the commonest sites of 
involvement. The latent period is usually long (median of 11 years) but may be 
as short as two years. The criteria for diagnosis are, a tumour developing in the 
path of radiation beam in a previously normal bone or region of benign tumour 
or non bone forming malignancy. There should be a symptom free latent period. 
Radiologically, the tumours are densely sclerotic or lytic with a soft tissue mass. 
50% cases show features of radiation osteitis (trabecular coarsening and lytic 
areas in the cortex). On microscopy, the tumours are usually of high grade with 
histological changes of radiation osteitis. 
PAROSTEAL OSTEOSARCOMA 
This is a low grade osteosarcoma arising from the surface of the bone. It has also 
been called juxtacortical osteosarcoma. The surface of distal posterior femur is 
the most common site of involvement.  A slight female preponderance has been 
noted. 
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X-Ray shows a heavily mineralised mass with a broad base, attached to the 
cortex with a tendency to encircle the bone. On macroscopic examination, the 
tumour presents as a cortex based mass that is hard with lobations. The 
occasional presence of a cartilage cap may suggest the diagnosis of 
osteochondroma. Invasion of surrounding soft tissues and bone marrow is seen. 
Microscopic features show a stroma with low cellularity with bony trabeculae 
that are well formed. Parallel arrangement of bony trabeculae may simulate 
normal bone. Osteoblastic rimming of bony trabeculae may or may not be seen. 
The hypocellular intertrabecular stroma shows minimal atypia. Cartilaginous 
differentiation may be evident in 50 % of tumours. Prognosis of these tumours is 
generally good with a high (>90%) five year survival rate. 
PERIOSTEAL OSTEOSARCOMA 
This tumour has been variably named as juxtacortical chondrosarcoma by 
Schajowicz and cortical osteosarcoma by Jaffe. 
This tumour accounts for less than 2% of all osteosarcomas. 
The peak incidence occurs at second and third decades with a slight male 
preponderance. The most common location of this tumour is the mid portion of 
femur followed by mid portion of tibia. The most common presenting complaint 
is a painless mass or swelling of long duration. Tenderness develops later in the 
course of the disease.  
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Radiologically, the tumour displays non homogenous, calcified spiculations 
disposed perpendicular to the cortex and giving a sun burst appearance. 
Macroscopically, the tumour arises from the bone surface and involves part or 
entire circumference of the bone. Histopathological examination shows that 
although chondroid differentiation may dominate, condensation of nuclei in the 
periphery of the lobules and production of trabeculae of bone in the centre 
supports the diagnosis of osteosarcoma. 
HIGH GRADE SURFACE OSTEOSARCOMA 
Very rarely, a highly anaplastic osteosarcoma occurs predominantly on the 
surface of the bone. This tumour has to be differentiated from the very well 
differentiated parosteal osteosarcoma and the moderately differentiated 
periosteal osteosarcoma. Patients are usually males in their second decade of 
life. Distal femur is the most frequent location of this tumour. The radiological 
appearance is that of a partially mineralised mass arising from the bone surface 
and extending into the soft tissues. Microscopic foci of medullary involvement 
may be seen.  Large areas of medullary tumour are against this diagnosis. 
Macroscopic examination shows the tumour attached to the surface with 
erosion of underlying cortex. All tumours have soft areas that help distinguish 
them from parosteal osteosarcomas. Histopathological spectrum is similar to 
that seen in conventional osteosarcomas with high grade spindle cells and lace 
like osteoid. These features help to distinguish it from parosteal osteosarcomas. 
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The FNAC (Fig.34) criteria for diagnosis are –  
- Pleomorphic spindle and rounded cells. 
- Tumour cells more or less resembling osteoblasts. 
- Multinucleated tumour cells. 
- Mitotic Figures. 
- Clumps of amorphous, faintly eosinophilic material in between cell 
clusters (osteoid). 
FIBROGENIC TUMOURS 
DESMOPLASTIC FIBROMA 
Desmoplastic fibroma is one of the rarest of bone tumours and may be 
considered to be an intraosseous counterpart of the much more common 
desmoid tumour of soft tissues. Gebhardt
36
 and co-authors found 85 cases in 
their review of literature. Also Kwon
37
 and co-authors found 47 cases of 
desmoplastic fibromas of jawbones reported in the literature. 
This is a locally aggressive non-metastasising lesion. Cytologically, typical 
fibroblasts are seen arranged in a collagenized stroma. Mean age of occurrence 
is by fourth decade and patients may have pain, swelling or fracture as their 
complaints. Metaphysis of long bones is most frequently involved. 
The radiographs show purely lucent defect in the bone. Slight to moderate 
expansion of the bone may be seen. 
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 Lobulated and well defined margins are seen. As described by Crim
38
 and co-
authors, there is a striking tendency for uneven bone destruction, leaving behind 
intact ridges of bone and producing a pseudo-trabecular appearance. On 
macroscopy, the tumour is gray and whorled. Microscopically, desmoplastic 
fibromas are composed of spindle cells with abundant collagen production. 
Bone entrapment may be seen. Soft tissue extension is also common. A 
prominent vascular component may be seen. Mitotic figures are usually absent. 
The chief differential diagnosis is fibrosarcoma which has nuclear atypia and 
increased cellularity. 
FIBROSARCOMA 
It is a malignant spindle cell neoplasm which produces moderate to sparse 
collagen matrix. No other matrix differentiation is seen either in the primary 
lesion or in the secondary deposits. Adults between 20 to 60 years of age are 
affected and metaphyseal ends of long bones especially around the knee are the 
commonest site. Patients may present with pain, swelling or pathological 
fracture. Predisposing factors like Paget’s disease, fibrous dysplasia, irradiated 
giant cell tumour, bone infarct or long standing osteomyelitis are found in one 
quarter of patients. 
Radiographically, the tumour appears lucent with a moth-eaten pattern. 
Tumour margins are irregular. Cortical destruction and soft tissue extension are 
commonly seen. Periosteal new bone formation may be minimal.  
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Taconis
39
 and Van Rijssel found that the radiographic features of fibrosarcoma 
and malignant fibrous histiocytoma are essentially the same. 
Fibrosarcoma in the bone has the same histopathologic features as its soft tissue 
counterpart. However, sections may show that it has invaded and destroyed the 
bone especially near the periphery of the tumour. There is wide variation in the 
degree of differentiation in the component fibroblasts and in the amount of 
collagen produced. The shape of the nuclei vary from long and slender to oval. 
Cells are organised in a herringbone pattern. 
Fibrosarcomas are graded (Table 4) on the basis of cytologic features of the 
tumour cells and cellularity of the lesion. Cellularity is inversely proportional to 
collagen produced. 
Table 4 - GRADING OF FIBROSARCOMAS 
GRADE FEATURES 
1 
Abundant collagen, spindle cells are separated from each other, 
nuclei elongated with tapered ends, mitotic figures uncommon. 
2 
Increased cellularity, nuclei more atypical, mitotic activity more 
prominent. 
3 
Darkly stained spindle cells in herringbone pattern, little collagen 
production, mitotic figures abundant, necrotic areas seen. 
4 
No matrix, cells packed closely together. Mitotic figures and necrotic 
areas very prominent. 
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Leiomyosarcoma, synovial sarcoma, malignant peripheral nerve sheath tumour, 
metastatic carcinoma and metastatic melanoma may also demonstrate a spindle 
cell pattern and should be considered in the differential diagnosis. Appropriate 
immunohistochemical studies are essential to arrive at the correct diagnosis. 
FIBROHISTIOCYTIC TUMOURS 
BENIGN FIBROUS HISTIOCYTOMA OF BONE 
 This is a very rare benign bone tumour. Females tend to get affected more 
frequently than males. Most of the patients have no findings attributable to their 
tumour.  The most common sites of involvement are long bones. X-ray 
examination reveals a well defined zone of rarefaction. Macroscopically, the 
tumour is firm and grey white with yellowish areas. On microscopic 
examination, the fibrogenic quality may be manifested by interlacing bundles 
of cells. Benign giant cells are present in variable numbers but they may be 
sparse. Some of the nuclei are indented or grooved, and this histiocytic quality 
may be associated with lipid production. Matsuno
40
 has referred to the problem 
of differentiating benign fibrous histiocytoma from giant cell tumour when the 
lesions occur at the ends of long bones. 
MALIGNANT FIBROUS HISTIOCYTOMA 
This is an uncommon bone tumour with most cases seen in males between fifty 
to seventy years of age. The commonest sites of occurrence are the lower 
extremities  particularly femur, followed by tibia.  
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Around 20 % of these tumours may be considered secondary to a variety of 
causes like Paget disease, radiation therapy, bone infarct and total hip 
arthroplasty. Troop
41
 and co-authors have reported a case of malignant fibrous 
histiocytoma at the site of previous hip replacement. A similar case was reported 
by Hagg
42
 and Adler.  Grossly, the tumour appears as a lobulated, fleshy, grey 
white mass. Microscopically, the tumour has variable presentation. Most 
tumours have a storiform pleomorphic pattern. Some may show a myxoid or 
predominantly giant cell pattern. Plump spindle cells are seen arranged in a 
matted pattern of short fascicles. Interspersed focal areas of large atypical cells, 
multinucleate giant cells and typical and atypical mitotic figures are seen. This 
tumour is largely a diagnosis of exclusion after various immunohistochemical 
markers have been studied to rule out other entities. 
EWING SARCOMA 
This is a small round cell malignant neoplasm of bone accounting for 6-8 % of 
primary malignant bone tumours. This tumour was earlier subject to high 
controversy as to whether all Ewing sarcoma were actually metastatic 
neuroblastomas.  
Essentially a tumour of childhood, most patients are younger than 20 years of 
age. Boys are affected more commonly than girls. The most common sites 
involved are diaphysis of long bones. Ribs and pelvic bones may also be 
commonly affected.  
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Patients report with pain and tenderness of several weeks duration in the 
affected bones. Most patients have a palpable tender mass and some have dilated 
veins over the tumour. An initial diagnosis of osteomyelitis may be suggested by 
fever, anemia, leukocytosis and elevated erythrocyte sedimentation rate. The 
radiologic and microscopic appearance of the tumour may also mimic 
osteomyelitis.  
Ewing tumour tends to be extensive, sometimes involving the entire shaft of a 
long bone. More bone is usually found to be pathologically involved than found 
in the radiograph. 
Radiologically (Fig.38), lytic destruction is the most common finding. There 
may however be regions of density due to stimulation of new bone formation. 
As the tumour bursts through the cortex, it raises the periosteum gradually. This 
elevation produces characteristic multiple layers of subperiosteal reactive new 
bone which produces the onion peel appearance of Ewing tumour. Radiating 
spicules from the cortex of an affected bone are not uncommon, a fact that 
complicates the differentiation from osteosarcoma. This differentiation may be 
especially difficult in flat bones like ilium. Edeiken
43
 has stressed that 
saucerisation of the exterior surface of the cortex is an early and characteristic 
sign of tumours presenting subperiosteally.  
Macroscopically, the tumour has a poorly demarcated, grayish white 
appearance with areas of haemorrhage, cystic degeneration and necrosis.  
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Microscopic examination (Fig.39) shows homogenous, densely packed small 
cells  with regular nuclei and finely granular nuclear chromatin. 1- 2 small 
nucleoli may be seen. The cell walls are indistinct and cytoplasm is delicate and 
lace like. Areas of haemorrhage and necrosis are usually seen. Most tumours 
show positivity for CD99 (Fig.39) antibody and vimentin. A microscopic 
differential diagnosis of osteomyelitis, eosinophilic granuloma and other small 
round cell tumours should be considered. Occasionally, the cells of the tumour 
contain nuclei that have a somewhat larger and less regular shape than those of a 
typical Ewing tumour. This has been named as atypical or large cell variant of 
Ewing tumour. Prognosis is similar to classical Ewing tumour. 
CD 99 is an immunostain that recognises a product of the MIC – 2 gene and has 
become a sensitive marker to diagnose Ewing sarcoma. The t(11;22) 
chromosomal translocation which results in EWS-FLI 1 fusion can be detected 
by molecular methods and may serve as a useful adjunctive test in diagnosis of 
Ewing sarcoma. 
Patients with Ewing sarcoma present with early metastasis to lung and other 
bones but with aggressive chemotherapy and radiotherapy, the outlook has 
greatly improved. 
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The criteria for diagnosis by FNAC are –  
- Clusters of loosely cohesive cells. 
- Two cell types – large pale cells with abundant cytoplasm and small 
dark cells with scanty cytoplasm. 
- Rounded or irregular bland nuclei; small nucleoli. 
- Occasional rosette like structures. 
HAEMATOPOIETIC TUMOURS 
PLASMA CELL MYELOMA 
Myeloma, a tumour of hematopoietic derivation is the most common primary 
neoplasm of the bone. The neoplasm is composed of plasma cells that show 
various degrees of differentiation. The tumour predominantly occurs in the sixth 
and seventh decades of life. Less than 7% of cases occur in the first four decades 
of life. The disease process consists of osteolytic lesions, bone pain, 
hypercalcemia and monoclonal gammopathy. Commonly involved bones 
include those that have haematological marrow in adults especially, vertebrae, 
ribs, skull, pelvis and scapula. In a review of the cases of 46 patients from Mayo 
Clinic files who had solitary plasmacytoma of bone, Frassica
44
 and co-authors 
found that 54 % lesions involved the vertebral column. Bone pain, pathological 
fracture, anaemia and hypercalcemia are the most common presenting 
symptoms.  
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The radiographic features result from the replacement of osseous structures by 
myelomatous masses. Radiologically (Fig.40), there are sharply demarcated 
punched out areas of lytic lesions not surrounded by a sclerotic zone. Expansion 
of the affected bones may produce a “ballooned out” appearance especially in 
the ribs. Variable osteoporosis and pathological fracture may be seen. Grossly, 
the myelomatous masses are soft, pink, or gray and friable, similar to currant 
jelly. Histopathological examination (Fig.41) shows sheets of closely packed 
round to oval plasma cells with little intercellular substance. The cells have 
abundant cytoplasm that tends to be granular and basophilic. The cell outlines 
are distinct with a characteristically round or oval eccentric nucleus. Two or 
even three nuclei may be observed in each cell. Well differentiated tumours 
show plasma cells with prominent clumping of chromatin producing a cart 
wheel appearance. With decreasing differentiation, nucleoli become enlarged 
and clumping of chromatin becomes less pronounced. Myelomas may become 
extremely vascular and show amyloid deposits. 
When in doubt whether the plasma cells are a part of neoplastic or inflammatory 
process, a monoclonal staining pattern for kappa or lambda will establish a 
diagnosis of malignancy. Neoplastic and non-neoplastic plasma cells usually 
express CD 138 (Fig.42). 
The FNAC diagnostic criteria are –  
- Many plasma cells 
- Single cell presentation 
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MALIGNANT LYMPHOMA 
Parker
45
 and Jackson, in 1939, first described malignant lymphoma of bone. A 
neoplasm composed of malignant lymphoid cells, this tumour accounts for about 
7% of all bone malignancies. In the series reported by Ostrowski
46
 and co-
authors in 1986 involving 422 patients with malignant lymphoma of bone, the 
tumours were considered to be primary in 179 cases. Older adults are most often 
affected with a slight male preponderance. Portions of bone with persistent red 
marrow are commonly involved with femur being the most common bone 
affected followed by ilium. Bone pain is the most frequent symptom. The 
radiological features of lymphoma are non-specific. Wilson and Pugh
47
, who 
studied the Mayo clinic series of lymphomas, concluded that the radiographic 
findings varied so much that they could not be regarded as characteristic. 
 Diaphyseal involvement is common in long bones. Grossly, the tumour tends to 
involve and destroy large portions of the bone. The process is poorly demarcated 
and there is a wide area of transition from normal bone. The tumour may be very 
sclerotic or purely lytic. Cortical destruction with a large soft tissue mass is 
common. Histopathologically (Fig.43), the majority of malignant lymphomas 
of bone are diffuse large B – cell lymphomas rather than follicular or small 
lymphocytic type. Most lymphomas of bone show a mixed cell infiltrate – that is 
there is considerable difference in the sizes and shapes of tumour cells.  
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Indeed, this feature is very helpful in differentiating lymphoma from Ewing 
tumour, the tumour cells of which show little variation in size and shape. Most 
lymphomas have a diffuse growth pattern. The tumour tends to permeate 
between normal structures like medullary bone and marrow fat. Dosoretz
48
 and 
co-authors have suggested that patients with tumours composed predominantly 
of large cleaved cells have a better prognosis than patients with tumours 
composed of non cleaved cells. Pettit
49
 and co-authors found that primary bone 
lymphoma has an unusually high incidence of large cleaved and multilobated 
cells. Immunohistochemical stains and occasionally molecular studies, are 
necessary for typing lymphomas of bone. Most of the times, the diagnosis can 
be made with a limited number of stains including the B – cell marker CD 20, 
the T – cell marker CD 3, and CD 45 (Fig.44). In the study of Ostrowski46 and 
co-authors, the 5 year survival for patients with primary lymphoma of bone was 
58%. 
GIANT CELL TUMOUR 
Giant cell tumour of bone is a distinctive neoplasm of undifferentiated cells. The 
multinucleated giant cells apparently result from fusion of the proliferating 
mononuclear cells, and although they are a constant and prominent part of these 
tumours, the giant cells are probably of less significance than mononuclear cells. 
If the stromal cells of a tumour that has many giant cells are malignant 
throughout, the tumour probably has no relationship to GCT.  
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The clinical correlative studies reported by Troup
50
 and co-workers in 1960 have 
fortified this concept. 
GCT constitutes 4-5 % of all primary bone tumours and about one fifth of all 
benign bone tumours. Most giant cell tumours are found at the ends (epiphysis) 
of long bones. Just less than half of these tumours occur around the knee joint, 
the distal femur being the most common single location. In the axial skeleton, 
sacrum is the commonest site. Small bones of the hands and feet are rarely 
involved (Fig.47&49). Skeletally mature individuals in their third and fourth 
decades of life are commonly affected. Female to male ratio is 1.5:1. The 
presenting complaints may be pain, swelling or pathological fracture. 
Radiograph (Fig.45&48) reveals a well-defined defect in epiphysis that is 
eccentrically located and extends to the  subchondral bone end plate of the 
articular surface. There is usually no sclerosis around the lesion. Gee
51
 and Pugh 
summarized the radiographic features of GCT. Campanacci
52
 and co-authors 
have developed a grading system for GCT based on radiographic appearance but 
they were not able to correlate the different stages with clinical outcome. 
Grossly (Fig.46), the tumour appears homogenous with a tan colour and 
moderately firm consistency. Some tumours have foci of haemorrhage and 
necrosis. Microscopic features (Fig.51) include a background of proliferating, 
homogenous mononuclear cells admixed with an evenly dispersed population of 
multinucleated giant cells. The mononuclear cells are round to ovoid in shape 
with relatively large nuclei and  inconspicuous nucleoli.  
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Some areas may show spindling out of cells simulating benign fibrous 
histiocytoma. Reactive bone formation has been observed at periphery of the 
tumour. Occasional tumour may show involutional changes with lipid-filled 
histiocytes. The chances of local recurrence after curettage are 50 %. The 
treatment of choice therefore is surgical excision.  
The FNAC (Fig.50) criteria for diagnosis are – 
- Abundant material. 
- A double population of cells – mononuclear spindle cells and giant 
cells of osteoclastic type. 
- Giant cells attached to the periphery of the clustered spindle cells. 
MALIGNANCY IN GIANT CELL TUMOUR 
Malignancy in a giant cell tumour  may be primary when a high grade sarcoma 
arises in a GCT or secondary when malignancy arises in a previously 
documented site of GCT. Evidence is increasing that radiation may trigger 
malignant transformation of giant cell tumours. Rock
53
 and co-authors reported 
on 19 cases of secondary malignant giant cell tumours and found a survival rate 
of 32 % at a mean of 9.6 years. 
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NOTOCHORDAL TUMOURS 
CHORDOMA 
This slow growing tumour arises from  remnants of the notochord. Therefore, in 
most cases it occurs in the midline of the axial skeleton. The sacrococcygeal 
region accounts for half  the cases . The tumour may also be found in the base of 
the skull and vertebral column.  Males are affected more frequently than women. 
The average age at diagnosis of sacral lesions is 55 years whereas that for 
spheno-occipital lesions is somewhat younger. The clinical symptoms depend on 
the location of the tumour. Pain is a nearly constant feature of sacrococcygeal 
chordoma, and it characteristically occurs at the tip of the spinal column. 
Constipation is also a common complaint. Spheno – occipital chordoma may 
cause symptoms referable to any of the cranial nerves. The radiologic (Fig.52) 
hallmark of chordoma is bone destruction. MRI greatly aids in localisation of 
the tumour. Focal calcifications are seen in half of the patients. In a study of 14 
cases of chordomas of the spine, de Bruine
54
 and Kroon found that 64% were 
sclerotic and the rest purely lytic. Grossly, these are soft encapsulated tumours 
with a bluish gray colour and extensive gelatinous translucent areas. Lobulations 
may be apparent on cut surface.  Recurrences often produce multiple nodules in 
the region of previous surgical excision. Metastasis is usually through  
haematogenous route. The process may develop in an unusual location, 
including the skin.  
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Su
55
 and co-authors reported involvement of the skin in 19 of 207 chordomas 
studied.  Microscopically (Fig.53), the tumour is separated into lobules by 
fibrous septae.  The tumour cells are arranged in cords and sheets. Cells have 
eosinophilic cytoplasm associated with both extra and intracellular mucin. The 
vacuoles in cells may be very prominent producing physaliphorous cells. 
Chondroid chordoma is a term coined by Heffelfinger
56
 and co-authors for 
neoplasms at the base of the brain that have features of both chordoma and 
chondrosarcoma. Positivity for both S-100 (Fig.55) protein and epithelial 
markers (Fig.54) is seen.  Radical excision of the tumour along with radiation 
therapy should be offered to patients. Fuch
57
 and co-authors reported on 52 
patients with sacral chordomas of whom 23 had local recurrence. 
The FNAC
58
 diagnostic criteria are –  
- Abundant myxoid ground substance encircling tumour cells. 
- Large cells with abundant bubbly cytoplasm (physaliphorous cells). 
- Clusters of medium sized epithelial – like cells. 
- Rounded nuclei, moderate anisokaryosis , bland chromatin. 
VASCULAR TUMOURS 
HEMANGIOMA 
These are relatively common, benign vaso formative neoplasms of endothelial 
origin. Vertebral bodies are the commonest sites followed by craniofacial  
skeleton and metaphyses of long bones.  
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Most tumours are clinically asymptomatic. Radiologically, well demarcated 
lucent masses containing coarse trabeculations are seen. Macroscopic 
appearance is that of a dark red mass. Microscopically, the tumour may be  a 
capillary or cavernous hemangioma composed of thin walled blood  vessels 
lined by single layer of endothelial cells. The vessels permeate the marrow and 
surround pre-existing trabeculae. 
ANGIOSARCOMA 
This rare malignant vascular tumour accounts for less than 1 % of all bone 
tumours. Age distribution of these tumours has a wide range from second to 
eighth decades of life. Long tubular bones of extremities and spine are 
commonly affected. Multicentricity is a common feature of these tumours. They 
present as painful lesions. Radiologically, these are purely lytic lesions. 
Clustering of multifocal lesions in a single anatomic location suggests the 
diagnosis of angiosarcoma. Macroscopically, the tumours are firm in 
consistency and bloody with absence of necrosis. The histological feature of 
angiosarcoma is tumour cells forming vascular spaces. 
SMOOTH MUSCLE TUMOURS 
LEIOMYOMA AND LEIOMYOSARCOMA 
Leiomyoma of  bone is an extremely rare tumour with  predilection for facial 
bones, especially mandible.  Tibia is a common site in the extragnathic skeleton.  
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Roentgenograms show radiolytic, often multilocular lesions. The lesions are 
firm gray tan on gross examination and similar to leiomyomas elsewhere on 
histological examination. Leiomyosarcoma of bone is extremely rare and 
metastasis from a leiomyosarcoma especially in the uterus has to be ruled out 
before making a diagnosis.  
 
LIPOGENIC TUMOURS 
LIPOMAS AND LIPOSARCOMAS 
Lipomas are rare tumours and incidental findings on radiological examination. 
The calcaneus is frequently involved. X-ray shows a well circumscribed lucent 
area with central calcification.  
Liposarcoma  is a very rare occurrence in the bone and very few cases have been 
documented so far in literature. 
NEURAL TUMOURS 
NEURILEMMOMA 
Schwannomas are very uncommon tumours with mandible and sacrum being 
affected more often. In a review of literature in 1992, Turk
59
 and co-authors 
found 79 examples of intra - osseous schwannomas. 
ADAMANTINOMA  
This tumour is a very rare, low grade, malignant, biphasic tumour. The anterior 
diaphysis of tibia is involved in 90% of cases. The prolonged clinical course of 
many patients indicates the slow growth of the tumour.  
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Pain is the most common symptom. The duration of symptoms before diagnosis 
varies from a few months to 50 years. In the series reported by Keeney
60
 and co-
authors, approximately one- third of patients had symptoms for more than 5 
years. Radiological examination shows a well circumscribed, lobulated 
osteolytic, cortical lesion with intralesional opacities. Grossly, the tumours have 
lobulated contours, are grey white and vary in consistency from firm and fibrous 
to soft and brain like. Histopathology reveals small epithelial islands in a 
fibrous stroma.  
METASTATIC MALIGNANCY 
After lungs and liver, metastatic deposits occur commonly in bones. 
Carcinomatous deposits are the most common malignant tumours seen in the 
human skeleton. Patients affected are usually in their fourth to sixth decade of 
life. 93% of all deposits originate from common  cancers like those of breast, 
prostate, lung, kidney and thyroid. Metastatic deposits in bone are rare in 
children; commonest primaries being – neuroblastoma, rhabdomyosarcoma and 
clear cell sarcoma of kidney. The commonly favoured sites of metastatic 
deposits in bone are the lumbar spine
61
 and proximal femur. In general, bones 
with persistent red marrow are affected. Small bones of hands and feet are 
almost never involved. The commonest presenting symptoms are pain, swelling 
or fracture.  
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Radiological examination (Table 5) (Fig.56&60) reveals lytic, blastic or 
mixed patterns. While prostatic deposits are osteoblastic, thyroid (Fig.56 - 59) 
and kidney deposits are purely lytic. Deposits from lung and breast (Fig.62) are 
irregularly lytic but may be osteoblastic. Vertebral deposits are difficult to detect 
using plain X-Ray. The macroscopic appearance varies depending on the 
primary tumour; osteoblastic metastases from breast are greyish white and firm 
as against soft haemorrhagic metastases from renal cell carcinoma. 
Table 5 Radiological appearance of  metastatic deposits from different primary sites  
Radiological appearance Primary malignancy 
 Lytic Thyroid and  kidney 
 Blastic Prostate 
 Lytic and blastic Lung and breast 
  
The diagnostic criteria for FNAC (Fig.61) are –  
- Foreign cell population. 
- Cell clusters; acinar or gland like structures. 
- Cells meeting criteria for malignancy. 
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MISCELLANEOUS LESIONS 
ANEURYSMAL BONE CYST 
This is a solitary, expansile lesion of unknown etiology. Usually, it is eccentric 
in location. Patients are most commonly under 20 years of age with swelling or 
pain as their presenting complaint. Most commonly involved bones are long 
bones or spine. Vertebral arches are usually affected. Radiologically (Fig.64 & 
65 ), the tumour presents as a lucent lesion in the shaft of the bone with 
trabeculated appearance. Periphery of the lesion is indistinct. MRI is helpful in 
demonstrating loculated pattern with fluid levels. Histologically (Fig.67), cystic 
spaces of various sizes filled with blood but without endothelial lining are seen. 
Fibrous septae containing giant cells and foci of immature bone are seen 
between the blood filled spaces. Haemosiderin laden cells and chronic 
inflammatory cells are also seen. 50%
62
 of aneurysmal bone cysts may occur 
secondary to osteoblastoma, chondroblastoma and fibrous dysplasia.  
Multiple sections should be studied to rule out telangiectatic osteosarcoma 
which may be radiographically and microscopically similar. 
SIMPLE CYST 
A benign, solitary cystic defect in the metaphyseal region of long bones, simple 
cysts are more common in children and young adolescents. Males are most often 
affected. 
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 Proximal humerus is the usual site of this lesion which usually presents with 
pathological fracture. On x-ray, the lesion appears as a well-defined lucent area 
with a thin sclerotic margin. Macroscopic examination shows a fluid filled cyst 
covered by a thin fibrous membrane. Microscopic examination shows a fibrous 
membrane lining the cyst. Secondary changes may occur after fracture through 
the cyst and present as haemorrhage, hemosiderin deposits, granulation tissue, 
cholesterol clefts, calcification, fibrin or reactive new bone formation. 
FIBROUS DYSPLASIA 
Fibrous dysplasia is a relatively common (5-7% of benign bone tumours)
63
 , 
slow growing, hamartomatous, solitary lesion which contains bone and fibrous 
tissue. Femur, tibia, skull, facial bones and ribs are most commonly affected. 
The lesion usually affects children and adolescents and most of the times, it 
remains  relatively unchanged throughout life. Polyostotic involvement may be 
seen in 25 % of affected cases. Deformity may occur if repeated minor fractures 
occur in the affected bone. The commonly affected bones are femur, tibia, skull 
or ribs.The classic ‘Shepherd’s Crook’ deformity occurs in the upper end of 
femur. The lesion is usually asymptomatic. The radiological appearance is that 
of a well defined lesion with ground glass appearance due to finely scattered 
bone islands. Grossly, there is fusiform expansion of bone with thinning of 
cortex and  replacement of bone by a firm whitish tissue of gritty consistency.  
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Microscopically, irregular foci of woven bony trabeculae  are seen in a cellular 
fibrous stroma. The bony trabeculae are characteristically arranged in Chinese 
letter pattern. Cartilage if present in the lesion may either be intrinsic to the 
lesion or secondary to fracture.  
OSTEOFIBROUS DYSPLASIA 
This lesion was originally described by Kempson
64
 in 1966 who believed it was 
an aggressive condition and named it ossifying fibroma. Campanacci
65
 thought it 
was a benign lesion and called it osteofibrous dysplasia. 
The lesion has a tendency to involve the tibia, more often the cortex. Most 
patients are affected in the first two decades of life. Radiographs (Fig.68) show 
multiple lucencies involving the anterior cortex of tibia with intervening 
sclerosis. Macroscopically, the tumour is solid with whitish or yellowish colour 
and soft or gritty texture.  The lesion is composed of spindle cell proliferation 
that may have a storiform pattern. Bony trabeculae show prominent osteoblastic 
rimming (Fig.69). The lesion tends to mature towards the periphery and seems 
to merge with cortical bone giving rise to zonation phenomenon.  
LANGERHANS CELL HISTIOCYTOSIS 
This disease is a neoplastic proliferation of Langerhans cells. It is a rare disorder 
and accounts for less than 1% of all bone lesions. Males are affected twice as 
commonly as females. 
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 60 % of cases occur under the age of 10 years though any age group may be 
affected. The skull, femur, pelvis, mandible and ribs are most commonly 
affected sites. Pain and swelling are the most common symptoms. Radiologic 
examination shows bony defects that are discretely defined and lytic. In the 
skull, there may be a “hole in a hole” appearance because of differential 
destruction of the two tables. Periosteal new bone formation may be seen.  The 
involved tissue is soft and red in colour on macroscopic examination. 
Microscopically, the lesion is composed of nests of   Langerhans cells admixed 
with inflammatory cells, predominantly eosinophils and also lymphocytes, 
neutrophils and plasma cells. In 1967, Enriquez
66
 and co-workers , in a study of 
116 patients with LCH at Mayo Clinic, found patients younger than 3 years, 
those with more than 3 bones involved, those with haemorrhagic manifestations 
and those with spelnomegaly all had ominous prognosis. 
The diagnostic criteria for FNAC are –  
- Large histiocytes with vescicular nuclei of irregular shape 
- Variable number of eosinophils 
- Giant cells of histiocytic type 
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MATERIALS AND METHODS 
This is a prospective study undertaken in the Department of Pathology, Madurai 
Medical College, Madurai during the period from May 2012 to July 2014. The 
Government Rajaji Hospital, Madurai is a tertiary health care centre catering to 
the population of Madurai as well as referrals from neighbouring districts. The 
surgical specimens and biopsy materials are processed and histopathological 
diagnosis is made in the Department of Pathology, Madurai Medical College, 
Madurai.  
INCLUSION CRITERIA 
Patients of all ages and both sexes with biopsy proven bone tumours and tumour 
like lesions were included in this study. 
 FNAC was performed on selected patients with clinico – radiological suspicion 
of bone tumours and tumour – like lesions. Patients were selected based on 
convenience sampling. 
EXCLUSION CRITERIA 
Patients with leukaemic infiltration of bone marrow were excluded from the 
study. 
 
68 
 
We received a total of 29,291specimens for histopathological examination 
during the study period. Out of these specimens, 8762 were neoplastic (both 
benign and malignant) lesions.  
Among the 8762 neoplastic lesions, 90 specimens were bone tumours and 
tumour like lesions.  
The study material included these 90 specimens (AnnexureVI A). 
The detailed clinical history and general and local examination findings of the 
patients were recorded in the proforma sheet (Annexure II). The radiological 
investigations like X-ray, CT scan and MRI were photographed and details of 
clinico – radiological diagnosis noted in the proforma sheet. 
The specimens were received in 10% neutral buffered formalin. Gross 
examination was done and dimensions of the received specimen were 
documented. The type of specimen whether biopsy/curettage, resection or 
amputation was noted. In case of resection or amputation specimens, the tumour 
site (epiphysis, metaphysis, diaphysis), medullary cavity involvement, joint 
involvement and soft tissue extension were recorded. 
Biopsy or curettage specimens were segregated as soft tissue and hard tissue. 
Soft tissue was submitted for processing and hard tissue was sent for 
decalcification. 
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Representative bits were taken from the resection and amputation specimens and 
submitted for processing. Decalcification was done using 10% aqueous solution 
of hydrochloric acid for hard tissues. After decalcification end point test, tissues 
were submitted for further processing.  
Tissue processing was done using automated tissue processor and sections of 3-
5 microns were cut manually using a microtome. Staining was done with routine 
haematoxylin and eosin stain.  (Annexure III) Slides were then examined under 
the light microscope. 
FNAC PROCEDURE 
FNAC was done on 15 patients with clinico – radiological suspicion of bone 
tumours. Patients were selected based on convenience sampling after getting 
written informed consent. 10 or 20 cc syringes and 18-22 gauge needles were 
used and a maximum of three passes were tried. FNAC was performed under 
strict aseptic precautions and local anaesthesia was given when required. Slides 
were fixed in isopropyl alcohol and stained with Haematoxylin and Eosin. Slides 
were examined under the light microscope and results were recorded in the 
master chart. (Annexure VI B). 
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IMMUNOHISTOCHEMISTRY 
In diagnostically challenging cases, where accurate diagnosis could not be 
arrived at by light microscopic examination of Hematoxylin and Eosin stained 
sections, specific immunohistochemical marker analysis was done.  
STATISTICAL ANALYSIS 
Cohen’s Kappa value was calculated to test the strength of agreement between 
Clinico – radiological diagnosis and histopathological diagnosis. 
The observations were then compared with other studies and inferences drawn. 
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OBSERVATIONS AND RESULTS 
This prospective study included 90 specimens of various benign and malignant 
bone tumours and tumour – like lesions. The total number of neoplasms 
diagnosed during the same study period in the Department Of Pathology of our 
college was 8762. Thus, bone tumours and tumour – like lesions constituted 
only 1.03 % of all neoplasms.  
The various benign tumours diagnosed were osteochondroma, enchondroma, 
chondromyxoid fibroma, osteoid osteoma, osteoblastoma and giant cell tumours.  
The malignant tumours diagnosed were chondrosarcoma, osteosarcoma, Ewing 
sarcoma, Plasma cell myeloma, malignant lymphoma, malignancy in giant cell 
tumour, chordoma and metastatic deposits.  
Only 4 cases of tumour – like lesions were received and included aneurysmal 
bone cyst and osteofibrous dysplasia. 
The distribution of bone lesions in our study is shown in Table 6 and Chart 1. 
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Table 6 - Distribution of bone lesions 
Category Frequency Percentage 
Benign 53 58.9% 
Malignant 33 36.7% 
Tumour – like lesions 4 4.4% 
Total 90 100% 
 
Chart 1 – Distribution of Bone lesions 
 
Benign tumours accounted for more than half the percentage of lesions (58.9%). 
Malignant tumours constituted 36.7% of the samples received. Tumour – like 
lesions were the least frequent constituting only 4.4% of all cases. 
  
58.90% 
36.70% 
4.40% 
Benign  
Malignant 
Tumour - like lesions 
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The gender distribution of the cases has been shown in Table 7 and Chart 2. 
 
Table 7 - Gender distribution of the cases 
 
 
 
 
 
   Male to female ratio  :  1.78:1 
 
Chart 2 - Gender distribution of cases 
 
The greater majority of patients were males constituting 64%  of the total cases. 
Just above one third of patients (36%) were females. 
 
FEMALES 
36% 
MALES 
64% 
Gender Frequency Percentage 
Female 32 36 
Male 58 64 
Total 90 100 
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The age distribution of cases received has been shown in Table 8 and Chart 3. 
Table 8 - Age distribution of cases 
Age in years Frequency Percentage 
< 10 9 10 
10-19 41 45.6 
20-29 11 12.2 
30-39 13 14.5 
40-49 2 2.2 
50-59 7 7.8 
60-69 6 6.6 
70-79 1 1.1 
Total 90 100 
 
Chart 3 - Age distribution of cases 
 
Majority of the patients were in their second decade (45.6%). Patients in their 
third and fourth decades constituted 12.2% and 14.5% of the cases respectively. 
Children below 10 years were seen to form 10% of the total sample. The 
youngest patient was 5 years old and the oldest was 70 years old. 
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The combined age and gender distribution of cases has been represented in 
Table 9 and Chart 4. 
Table 9 - Age and gender distribution of cases 
Age in 
Yrs 
Gender 
Total 
Male Female 
<10 7 12.1% 2 6.3% 9 10% 
10-19 30 51.7% 11 34.3% 41 45.6% 
20-29 7 12.1% 4 12.5% 11 12.2% 
30-39 6 10.3% 7 21.9% 13 14.5% 
40-49 2 3.5% 0 0% 2 2.2% 
50-59 2 3.5% 5 15.6% 7 7.8% 
60-69 3 5.2% 3 9.4% 6 6.6% 
70-79 1 1.6% 0 0% 1 1.1% 
Total 58 100% 32 100% 90% 100% 
 
Chart 4 - Age and gender distribution of cases 
 
The second decade was the commonest age – group of bone lesions in males as 
well as females. 
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The gender distribution of bone tumours and tumour like lesions has been shown 
in Table 10 . 
Table 10  – Gender distribution of bone tumours and tumour -  like lesions 
Categories 
Gender 
Total 
Male Female 
Osteochondroma 
 
28 48.3% 7 21.9% 35 38.9% 
Enchondroma 
 
0 0% 1 3.1% 1 1.1% 
Chondromyxoid fibroma 
 
0 0% 1 3.1% 1 1.1% 
Chondrosarcoma 
 
0 0% 2 6.3% 2 2.3% 
Osteoid osteoma 
 
4 6.9% 0 0% 4 4.4% 
Osteoblastoma 
 
1 1.7% 0 0% 1 1.1% 
Osteosarcoma 
 
8 13.8 3 9.4% 11 12.2 
Ewing sarcoma 
 
2 3.4% 
 
2 6.3% 4 4.4% 
Plasma cell myeloma 
 
1 1.7% 1 3.1% 2 2.3% 
Malignant lymphoma 
 
1 1.7% 0 0% 1 1.1% 
GCT 
 
7 12.1% 4 12.5% 11 12.2% 
Malignancy in GCT 
 
1 1.7% 0 0% 1 1.2 % 
Chordoma 
 
0 0% 1 3.1% 1 1.1% 
Metastatic malignancy 
 
3 5.3% 8 25% 11 12.2% 
ABC 
 
2 3.4% 1 3.1% 3 3.3% 
Osteofibrous dysplasia 
 
0 0% 1 3.1% 1 1.1% 
Total 
 
58 100% 32 100% 90 100% 
 
The most common tumour in males and females was osteochondroma 
constituting 48.3% of cases in males and 21.9% in females. 
There were 4 cases of osteoid osteoma and all were seen in males. 
Metastatic deposits showed a predilection for females in this study constituting 
25% of all cases in females as against only 5.3% of all cases in males. 
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Distribution of cases based on histopathologic diagnosis has been shown in 
Table 11 and Chart 6. 
Table 11- Distribution of cases based on Histopathological diagnosis 
S.No Pathological diagnosis Frequency Percentage 
1 Osteochondroma 35 38.9 
2 Enchondroma 1 1.1 
3 Chondromyxoid fibroma 1 1.1 
4 Chondrosarcoma 2 2.3 
5 Osteoid osteoma 4 4.4 
6 Osteoblastoma 1 1.1 
7 Osteosarcoma 11 12.2 
8 Ewing sarcoma 4 4.4 
9 Plasma cell myeloma 2 2.3 
10 Malignant lymphoma 1 1.1 
11 GCT 11 12.2 
12 Malignancy in GCT 1 1.2 
13 Chordoma 1 1.1 
14 Metastatic malignancy 11 12.2 
15 ABC 3 3.3 
16 Osteofibrous dysplasia 1 1.1 
 Total 90 100 
 
Chart 6  -  Distribution of cases based on Histopathological diagnosis 
 
The commonest tumour encountered in this study was osteochondroma (38.9%). 
Giant cell tumours, metastatic malignancy and osteosarcomas were the other 
common tumours amounting to 12.2% each. 
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The age distribution of the cases based on behaviour of bone lesions is given in 
Table 12 and Chart 7 . 
Table 12 - Age distribution of cases based on behaviour of bone lesions 
Age in Yrs 
Tumour 
Total 
Benign 
Malignant 
primary 
Metastasis 
Tumour 
like 
lesions 
<10 
7 2 0 0 9 
77.8% 22.2% 0% 0% 100% 
10-19 
29 10 0 2 41 
70.7% 24.4% 0% 4.9% 100% 
20-29 
8 2 0 1 11 
72.7% 18.3% 0% 9% 100% 
30-39 
7 3 2 1 13 
53.9% 23.1% 15.3% 7.7 100% 
40-49 
1 1 0 0 2 
50% 50% 0% 0% 100% 
50-59 
0 2 5 0 7 
0% 28.6% 71.4% 0% 100% 
60-69 
1 2 3 0 6 
16.7% 33.3% 50% 0% 100% 
70-79 
0 0 1 0 1 
0% 0% 100% 0% 100% 
 
Chart 7 - Age distribution of cases based on behaviour of bone lesions 
 
 
Benign tumours were nearly equally distributed in the first few decades of life. 
Metastatic malignancy was commonest in the fifth, sixth and seventh decades of 
life. 
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The gender distribution of cases based on behaviour of bone lesions has been 
depicted in Table 13  and Chart 8. 
Table 13 - Gender distribution of cases based on behaviour of bone lesions 
 
Category 
Total 
Benign 
Malignant 
primary 
Metastasis 
Tumour 
like lesions 
Male 
40 13 3 2 58 
68.9% 22.4% 5.2% 3.5% 100% 
Female 
13 9 8 2 32 
40.6% 28.1% 25% 6.3% 100% 
Total 
53 22 11 4 90 
58.9% 24.4% 12.2% 4.5% 100% 
 
Chart 8   - Gender distribution of cases based on behaviour of bone lesions 
 
In our study, benign tumours were encountered more commonly in males. The 
percentage of females with a diagnosis of primary malignancy was 28.1% as 
against 22.4% of males. Metastatic malignancy was also more common in 
females (25%) as against only 5.2% in males. 
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The distribution of cases based on presenting symptoms has been shown in 
Table 14 and Chart 9 . 
Table 14 - Distribution of presenting symptoms 
Symptoms Frequency Percentage 
Pain 10 11.1% 
Swelling 57 63.3% 
Pain and swelling 12 13.4% 
Fracture 9 10% 
Pain and difficulty in walking 1 1.1% 
Constipation 1 1.1% 
Total 90 100% 
 
Chart 9 - Distribution of presenting symptoms 
 
 
63% of the patients presented with swelling as their chief complaint. 
Pain along with swelling was the next common complaint (14%). 
One patient with chordoma had constipation for 6 months. Another patient  
diagnosed with plasmacytoma of spine had pain with difficulty in walking. 
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The age distribution of giant cell tumours  and osteosarcomas has been shown in 
Table 15 and Chart 10.  
 
Table  15 -  Age distribution of giant cell tumours and osteosarcomas 
 
Age group ( years) GCT Osteosarcoma 
<10 0 0% 1 9.1% 
10-19 3 27.3% 7 63.6% 
20-29 3 27.3% 2 18.2% 
30-39 4 36.3% 0 0% 
40-49 1 9.1% 0 0% 
50-59 0 0% 1 9.1% 
Total 11 100% 11 100% 
 
 
Chart 10 -  Age distribution of giant cell tumours and osteosarcomas 
 
 
 
There was a clustering of cases of osteosarcoma in the second decade of life 
(63.6% of all osteosarcomas). 
36.3% of giant cell tumours occurred in patients in the age group of 30-39 years. 
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The distribution of cases based on radiological findings has been shown in Table 
16 and Chart  11. 
Table 16 -  Distribution of radiological findings of bone lesions 
Radiological finding Frequency Percentage 
Lytic with rim of sclerosis 4 4.4% 
Lytic  with well defined lesion 10 11.1% 
Lytic with poorly defined lesion 18 20% 
Permeative lysis 5 5.6% 
Sclerotic 3 3.3% 
Lytic and sclerotic 13 14.4% 
Lytic with specs of calcifications 2 2.2% 
Lesion with cartilage cap 35 38.9% 
Total 90 100% 
  
Chart 11 - Distribution of radiological findings of bone lesions 
 
 
Among the lytic lesions, the commonest radiological finding was that of a 
poorly defined lytic lesion. 
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The distribution of cases based on radiological findings and behaviour of bone 
lesions is given in Table 17 . 
Table 17 - Distribution of cases based on radiological findings and 
behaviour of bone lesions. 
Radiologic finding 
Tumour 
Total 
Benign 
Malignant 
primary 
Metastasis 
Tumour – like 
lesion 
Lytic with rim of 
sclerosis 
1 0 0 3 4 
Lytic with well 
defined lesion 
9 0 0 1 10 
Lytic with poorly 
defined lesion 
5 5 8 0 18 
Permeative lysis 
 
0 5 0 0 5 
Sclerotic 
 
3 0 0 0 3 
Lytic and sclerotic 
 
0 10 3 0 13 
Lytic with specs of 
calcificaion 
0 2 0 0 2 
Lesion with cartilage 
cap 
35 0 0 0 35 
Total 
 
53 22 11 4 90 
 
Among the primary malignant tumours, the commonest radiological appearance 
was of lytic and sclerotic type seen in ten cases. Poorly defined lytic lesions and 
permeative lysis were seen in five cases each. 
 
Eight metastatic deposits produced poorly defined lytic lesions on radiograph 
while three had a lytic and sclerotic appearance. 
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Distribution of cases based on bone involved has been shown in Table 18 and 
Figure -11 .  
 
 
Table 18 -  Distribution of bone lesions based on bone involved. 
Bone involved Site Frequency Total Percent 
Humerus 
Proximal 13 
16 17.8% Shaft 3 
Distal 0 
Radius Distal 4 4 4.5% 
Ulna Distal 1 1 1.1% 
Scapula  4 4 4.5% 
Metacarpal  2 2 2.2% 
Femur 
Proximal 5 
26 28.9% Shaft 7 
Distal 14 
Tibia 
Proximal 7 
19 21.1 Shaft 1 
Distal 1 
Fibula 
Proximal 3 
4 4.4% 
Distal 1 
Ilium  5 5 5.6% 
Phalanx  2 2 2.2% 
Skull  1 1 1.1% 
Spine 
Vertebra 3 
4 4.4% 
Sacrum 1 
Sternum  2 2 2.2% 
 
The commonest bones involved were femur, tibia and humerus with 28.9%, 
21.1% and 17.8% cases respectively.  
23.3% of the lesions occurred around the knee joint ( distal femur and proximal 
tibia). Involvement of  the axial skeleton occurred in 13.3% of the cases. 
Small bone involvement was seen in 4.4% of the cases. 
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Figure.11 -  Pictorial representation of bones involved by bone tumours and 
tumour – like lesions. 
 
 
Fig.11 
 
 
 
 
 
 
 
86 
 
The distribution of bone lesions based on site of involvement is shown in Table 
19 and Chart  12 . 
Table 19 -  Distribution of bone lesions based on site of involvement 
Site involved Frequency Percent 
Epiphysis 7 7.8% 
Metaphysis 44 48.9% 
Diaphysis 10 11.1% 
Epi-metaphysis 4 4.4% 
Meta-diaphysis 8 8.9% 
Flat bones 16 17.8% 
Apophysis 1 1.1% 
Total 90 100% 
 
Chart 12 -  Distribution of bone lesions based on site of involvement 
 
Nearly half ( 48.9% ) of lesions were seen to occur in the metaphysis. 
Flat bones were affected in 17.8 % of the cases. 
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The distribution of sites of metastatic deposits is shown in Table 20  
and Chart 13. 
Table 20 - Distribution of sites of metastatic deposits 
Bone Frequency Percentage 
Femur 4 36.4% 
Humerus 3 27.3% 
Skull 1 9.1% 
Spine 1 9.1% 
Sternum 2 18.1% 
Total 11 100% 
 
Chart 13 -  Distribution of sites of metastatic deposits 
 
Femur was the most common bone involved by metastatic deposits  (36.4%).  
Bones of the axial skeleton put together ( Skull, Spine, Sternum) accounted for 
36.3% of all metastatic deposits. 
 
 
 
 
36.40% 
27.30% 
9.10% 
9.10% 
18.10% 
Femur 
Humerus 
Skull 
Spine 
Sternum 
88 
 
The distribution of sites of occurrence of osteosarcoma have been shown in 
Table 21 and Chart 14 
Table 21 – Distribution of sites of occurrence of osteosarcoma 
Bone Frequency Percentage 
Distal femur 4 36.4% 
Proximal tibia 3 27.2% 
Proximal humerus 1 9.1% 
Distal radius 1 9.1% 
Proximal fibula 1 9.1% 
Ilium 1 9.1% 
Total 11 100% 
 
Chart 14 -  Distribution of sites of occurrence of osteosarcoma 
 
 
63.6 % of all osteosarcomas occurred around the knee joint ( distal femur and 
proximal tibia). Distal end of femur was the bone most commonly involved by 
osteosarcoma (36.4%). 
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Distribution of sites of occurrence of osteochondromas is shown in Table 22 and 
Chart 15 
Table 22 -  Distribution of sites of occurrence of osteochondromas 
Bone Frequency Percentage 
Femur 9 25.7% 
Tibia 6 17.1% 
Fibula 2 5.7% 
Humerus 10 28.6% 
Scapula 3 8.6% 
Phalanx 1 2.9% 
Ilium 2 5.7% 
Radius 2 5.7% 
Total 35 100% 
 
Chart 15 - Distribution of sites of occurrence of osteochondromas 
 
Osteochondromas showed involvement of many bones with humerus being most 
commonly involved (28.6%) followed closely by femur (25.7%). 
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The distribution of lesions based on WHO classification has been depicted in 
Table 23  and chart 16. 
Table 23 - Distribution of cases based on WHO classification 
WHO Category Frequency Percentage 
Cartilage tumours 39 43.3 
Osteogenic tumours 16 17.8 
Ewing sarcoma /PNET 4 4.5 
Haematopoietic tumours 3 3.3 
GCT 12 13.3 
Notochordal tumour 1 1.1 
Miscellaneous tumours 11 12.2 
Miscellaneous lesions 4 4.5 
Total 90 100 
 
Chart 16  - Distribution of cases based on WHO classification 
 
Cartilage tumours constituted the single largest category (43.3%) followed by 
osteogenic tumours (18.9%). 
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The distribution of cases based on behaviour of lesions is tabulated in Table 24.  
Table 24 - Distribution of cases based on behaviour of bone lesions 
Category Pathological diagnosis Frequency Percentage 
Benign 
Osteochondroma 35 66 
Chondroma 1 1.9 
Chondromyxoid fibroma 1 1.9 
Osteoid osteoma 4 7.5 
Osteoblastoma 1 1.9 
GCT 11 20.8 
Total 53 100 
Malignant 
primary 
Chondrosarcoma 2 9.1 
Osteosarcoma 11 50 
Ewing sarcoma 4 18.3 
Malignant lymphoma 1 4.5 
Malignancy in GCT 1 4.5 
Plasma cell myeloma 2 9.1 
Chordoma 1 4.5 
Total 22 100 
Metastasis Metastasis 11 100 
Tumour like 
lesions 
ABC 3 75 
Osteofibrous dysplasia 1 25 
Total 4 100 
 
Osteochondroma was the commonest benign tumour constituting 66% of all 
benign tumours followed by giant cell tumour (20.8%). 50% of all primary 
malignant tumours were osteosarcomas. Ewing Sarcoma was  the second most 
common  primary malignant tumour amounting to 18.3% of cases.                                                                        
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Distribution of  bone tumours in the paediatric age-group (0-18 years) has been 
shown in Table 25 and Chart 17. 
Table 25 - Distribution of paediatric bone tumours 
Bone tumour Frequency Percentage 
Osteosarcoma 8 17.4% 
Ewing sarcoma 4 8.7% 
Giant cell tumour 2 4.3% 
Osteochondroma 28 60.9% 
Osteoid osteoma 2 4.3% 
Osteofibrous dysplasia 1 2.2% 
Aneurysmal bone cyst 1 2.2% 
Total 46 100% 
 
Chart  17 - Distribution of paediatric bone tumours 
 
The commonest paediatric bone tumour was osteochondroma (60.9%). 
Osteosarcoma was the commonest primary malignancy in the paediatric age 
group (17.4%). 
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Clinico – radiological versus histopathological diagnosis has been tabulated in 
Table 26. 
Table 26 -  Clinico – Radiological versus Histopathological Diagnosis 
 
 Histopathological Diagnosis Total 
Clinico 
radiological 
diagnosis 
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Osteochondroma 35                35 
Chondroma  1         1      2 
CMF   1              1 
Chondrosarcoma    2             2 
Osteoid osteoma     4            4 
Osteoblastoma      1           1 
Osteosarcoma       10          10 
Ewing sarcoma       1 4         5 
Plasma cell 
myeloma 
         1       1 
Malignant 
lymphoma 
        1        1 
GCT           11      11 
Malignancy in 
GCT 
           1     1 
Chordoma             1    1 
Metastasis              11   11 
ABC               3  3 
Osteofibrous 
dysplasia 
               1 1 
Pott’s spine         1        1 
                 90 
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Considering all bone lesions together, clinico - radiological diagnosis was 
confirmed by similar histopathological diagnosis in 85 out of the 90 cases 
(94.44%).  
The histopathological diagnosis was not in agreement with clinico – radiological 
diagnosis  in 5 out of the total of 90 cases. 
The corresponding Cohen’s Kappa value calculated was 0.943. This showed 
excellent agreement between clinico – radiological and histopathological 
diagnoses of  bone tumours and tumour – like lesions in this study. 
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FNAC was performed in 15 cases of bone tumours.  
The distribution of bone tumours based on the results of FNAC are shown in 
Table 27 and Chart 18. 
Table 27 - Distribution of bone tumours based on results of FNAC 
FNAC diagnostic categories Frequency Percentage 
Osteosarcoma 3 20 
GCT 5 33.3 
Sarcoma, not otherwise 
specified 
2 13.3 
Plasma cell myeloma 1 6.7 
Metastatic adenocarcinomatous 
deposits 
1 6.7 
Inadequate for evaluation 3 20 
Total 15 100 
 
Chart 18  - Distribution of bone tumours based on results of FNAC 
 
Giant cell tumour was the commonest diagnosis made comprising 33.3% of all 
cases. 
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 Fig.12 - Macroscopic appearance of  osteochondroma – thin and smooth cartilage cap 
with underlying bone. Case 1866/12. 
 
 
 
 
 
 
 
 
 
Fig.13- Anteroposterior radiograph of an 
osteochondroma involving right femur. 
Lesion characteristically pointing away 
from the joint. Case 152/14. 
 
Fig.14 – Osteochondroma. Contrast 
enhanced axial CT section of pelvis 
showing an exophytic lobulated cortical 
mass arising from right iliac blade with 
medullary continuity. Case 1839/13. 
 
 Fig.15 - Osteochondroma with cartilage cap. Chondrocytes have an orderly 
arrangement in the cartilage cap and there is maturation into trabecular bone.        
(H&E scanner view) Inset shows columnar arrangement of chondrocytes towards the 
base. (H&E x 400)  Case 1866/12. 
 
Fig.16 - Enchondroma with lobules of hypocellular cartilage.                                        
(H&E x 100)  Case 5068/13. 
 Fig. 17 - Chondromyxoid fibroma. Lobular pattern. Lobules have a hypocellular centre 
with condensation of tumour cells towards the periphery. (H&E x 100) Case 2637/13. 
 
 
Fig . 18 - Chondrosarcoma of phalanx. Tumour invades pre-existing bone.                        
(H&E Scanner view) Case 3954/12. 
 Fig.19 -  Chondrosarcoma right scapula. MRI – T2 weighted fat saturated coronal 
image of right shoulder region showing heterogeneously hyperintense large mass with 
internal T2 hypointense areas. Case 2903/14. 
 
 
Fig.20 -  Gross cut surface of chondrosarcoma. Resection specimen of scapula.          
Gray  white lobulated tumour with degenerative myxoid change. Case 2903/14. 
 Fig.21 -  Grade-II chondrosarcoma. Increased cellularity, nuclear enlargement and 
hyperchromasia. (H&E x 100)  Case 2903/14. 
 
 
Fig.22 - Binucleated chondrocytes. Moderate nuclear atypia and pleomorphism in grade 
II chondrosarcoma. (H&E x 400) Case 2903/14. 
 Fig.23 - CT scan left leg – upper part of shaft of tibia showing intracortical cystic lesion 
with internal nidus and surrounding reactive sclerosis. Case 2349/13. 
 
 
Fig.24  - Macroscopic appearance of osteoid osteoma. Nidus forming a circumscribed 
nodule surrounded by a thick shell of bone. Case 2349/13. 
 Fig.25 -  Osteoid osteoma. Well circumscribed vascularised nidus surrounded by 
reactive bone. (H&E x 100) Case 2349/13. 
 
 
Fig.26 - Osteoblastoma. Anastamosing bony trabeculae in a loose fibrovascular stroma. 
(H&E x 400). Inset shows well circumscribed edge of the lesion. (H&E scanner view) 
Case 5048/13. 
 Fig.27 - Clinical presentation of osteosarcoma - distal end of radius in a 17 year old boy. 
Case 2472/13. 
 
 
 
Fig.28 - Clinical presentation of osteosarcoma distal end of tibia with fibular 
involvement.  Ulceration due to stretching of skin by the tumour. Case 3018/13. 
 
 
 
 
 
 
Fig.29 - Osteosarcoma distal tibia with 
fibular involvement. Plain radiograph. 
Mixed lytic – sclerotic mass with sunray 
type of periosteal reaction. Cloud like 
matrix mineralisation seen. Case 3018/13. 
Fig.30 - Osteosarcoma distal femur. MRI 
T2 weighted image. Sagittal plane of knee 
joint. Case 1221/13. 
 
 
 
Fig.31- Macroscopic cut surface appearance of osteosarcoma in above knee amputation 
specimen. Tumour involving distal metadiaphyseal region of right femur with soft tissue 
extension. Case 1221/13. 
 Fig. 32 - Osteosarcoma; malignant stromal cells with osteoid production.                   
(H&E Scanner view) Case 1221/13. 
 
 
Fig.33 - Osteosarcoma with giant cells. The nuclei of malignant stromal cells are 
pleomorphic and vesicular as against benign looking nuclei of giant cells.                  
(H&E x 400)  Case 1221/13. 
 Fig .34 - FNAC. Scattered and small groups of pleomorphic sarcoma cells with strands 
of intercellular pink material consistent with osteoid. (H&E x 400) Case Cy 1461/13. 
 
 
Fig.35 - Osteoblastic osteosarcoma. Malignant tumour cells with lace like filigree pattern 
osteoid. (H&E x 400) Case 4202/12. 
 Fig.36 - Fibroblastic osteosarcoma. Malignant osteoid production is present between 
malignant spindle cells. (H&E x 400) Case 2473/13. 
 
 
Fig.37- Telangiectatic osteosarcoma. This tumour occurred at the site of a biopsy proven 
GCT. Haemorrhagic spaces separated by septae. (H&E scanner view) Inset on the left 
shows malignant tumour cells lining the septae and on the right shows focal production 
of malignant osteoid. (H&E x 400) Case 2206/13. 
 Fig.38 - Ewing sarcoma. MRI pelvis. Diffuse ill – defined permeative type of lytic lesion 
involving entire right iliac bone. Case 3231/13. 
 
Fig.39 - Ewing sarcoma. Sheets of tumour cells with uniform round nuclei. Rosette 
formation seen. (H&E x400). Inset shows membrane positivity of tumour cells with 
CD99 immunostain. Case 3030/12. 
 Fig.40 -  Plasma cell myeloma of right humerus. X- Ray of right shoulder joint in AP 
view showing large expansile ill – marginated lytic lesion involving upper                    
meta – diaphyseal region of humerus with apparent trabeculations. Case 5408/13. 
 
 
 
 
 
 
 
Fig. 41 – Plasma cell myeloma. Sheets of 
plasma cells. Arrow indicates binucleate 
plasma cell. Case 4061/13. 
Fig.42 - CD 138 positive plasma cells. 
Case 4061/13. 
 Fig.43 - Primary malignant lymphoma of bone. Polymorphic tumour cells with nuclear 
irregularities and prominent nucleoli. (H&E x 400) Case 186/14. 
 
 
Fig.44 - Strong CD45 positivity of lymphoma cells. Case 186/14. 
 
 Fig.45 - Recurrent GCT of proximal tibia. Plain radiograph in AP view. Bone graft seen 
with evidence of recurrent expansile lytic lesion in proximal tibia. Case 1925/13. 
 
 
Fig.46 - Proximal tibial resection for recurrent GCT. Characteristic red brown tumour 
destroying the cortex. Case 1925/13. 
 Fig.47 - Clinical presentation of GCT – 4th metacarpal. Case 4552/13. 
 
 
Fig.48 -  Radiograph of hand in oblique view showing lytic lesion destroying the 4
th
 
metacarpal. Case 4552/13. 
 
 
Fig.49 - Ray amputation specimen of GCT 4
th
 metacarpal. Tumour extends into the 
epiphysis. Case 4552/13. 
 Fig.50 - FNAC from a case of GCT showing spindle shaped stromal cells and osteoclastic 
giant cells. (H&E x 400)  Case Cy 756/13. 
 
 
Fig .51 - GCT – Multi nucleated giant cells arranged uniformly in a background of 
mononuclear cells. Case 4552/13. 
 Fig.52 – Chordoma. TI weighted non – fat saturated MRI of pelvis in coronal view 
showing homogenously hypo intense lobulated lesion in sacral region.  Case 480 /13. 
 
Fig.53 - Chordoma – cords and strands of tumour cells in a mucinous background. 
Physaliferous cells with abundant vacuolated cytoplasm seen. (H&E x 400)  Case 480/13. 
 Fig.54 - Cytokeratin positivity in chordoma. Case 480/13. 
 
 
 
Fig.55 - Physaliferous cells positive for S - 100 immunostain. Case 480/13. 
 
 Fig.56 -  Metastatic deposits in skull and brain from occult primary in thyroid. Axial 
contrast enhanced CT section of head showing lytic destructive lesion of right parietal 
bone with large homogenously enhancing associated soft tissue component both on scalp 
and intracranial extra axial region indenting underlying brain. Case 1321/13. 
   
 
 
 
Fig.57 - Metastatic follicular carcinoma thyroid invading the skull bone and brain 
parenchyma. (H&E x 100) Case 1321/13. 
 Fig .58 - TTF – 1 immunostain. Nuclear positivity of follicular cells in metastatic 
follicular carcinoma thyroid . Case 1321/13. 
 
 
Fig.59 - Thyroglobulin immunostain. Colloid staining positive in metastatic follicular 
carcinoma thyroid. Case 1321/13. 
 Fig.60 -  Carcinomatous deposits in shaft of femur from a primary in the breast in a 39 
year old female. X-ray upper thigh in AP view showing permeative lytic destructive 
lesion of mid – diaphysis of femur with cortical breach. Case 819/13. 
 
 
Fig.61 -  FNAC from costo-chondral metastatic deposits of breast carcinoma. Scattered 
and clusters of pleomorphic tumour cells. Inset shows ductal pattern of arrangement of 
tumour cells. (H&E x 400) Case Cy 230/13. 
 Fig.62 - Metastatic adenocarcinomatous deposits. Bony trabeculae infiltrated by nests 
and cords of pleomorphic tumour cells. (H&E x400) Case 819/13. 
 
Fig.63 - Metastatic squamous cell carcinoma deposits in the sternum of a 60 year old 
woman. (H&E x 400)  Case 370/13. 
 Fig.64 - Aneurysmal Bone Cyst. Plain radiograph. Lytic lesion in greater trochanter of 
femur. Thin sclerotic rim present. Case 5249/13. 
 
 
Fig.65 -   Aneurysmal Bone Cyst of distal fibula. Plain radiograph, lateral view of lower 
leg revealing well circumscribed expansile radiolucent lesion in lower metaphysis of 
fibula with thin ballooned out intact cortex and faintly appreciable internal septations. 
Case 2035/13. 
 
 Fig.66 - Macroscopic appearance of distal fibular resection for ABC. Inset shows cut 
surface with internal sepate and haemorrhagic material. Case 2035/13. 
 
 
Fig.67 -  Aneurysmal Bone Cyst. Cystic spaces separated by septae containing 
fibroblasts, benign giant cells and immature bone . (H&E x 400) Case 5249/13. 
 Fig.68 - Osteofibrous dysplasia. Plain radiograph, lateral view of knee joint showing well 
defined lytic cortical based lesion in the proximal diaphysis of tibia with sclerotic 
scalloped margins and fine intralesional dense septae. Case 1668/14. 
 
 
Fig.69 - Osteofibrous dysplasia. Immature bone trabeculae with osteoblastic rimming 
and surrounding fibrous stroma. (H&E x 400)  Case 1668/14. 
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DISCUSSION 
Histological examination of bone tumours is considered to be a challenging field 
in pathology. Bone tumours and tumour – like lesions are very rare. The low 
incidence of these tumours and the resulting limited experience in dealing with 
them adds to the diagnostic difficulties. Clinico – radiological evaluation of 
bone tumours and tumour – like lesions is an essential part of patient 
management. Histopathological diagnosis should be given after proper review of 
clinical and radiological findings. It is difficult to evaluate the precise incidence 
of bone tumours as many benign lesions may not be biopsied. 
This present study had 90 bone tumours and tumour – like lesions. An attempt 
has been made to categorise the cases and study their histopathology. Age 
distribution and gender distribution of the cases have been studied. An attempt 
has also been made to evaluate the level of agreement between clinico -  
radiological and histopathological diagnosis of bone tumours and tumour – like 
lesions. FNAC study has been attempted in 15 cases of bone tumours. 
Immunohistochemical markers have been used to categorise the lesions in case 
of diagnostic difficulty. 
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I. BEHAVIOUR OF THE BONE LESION 
 1) The comparison of data from different studies for classification of bone 
lesions based on behaviour has been shown in Table 28. 
Table 28 - Comparison of data from different studies done on classification 
of bone lesions based on behaviour 
Study 
Total 
cases 
Benign Malignant 
Tumour – like 
lesions 
No. % No. % No. % 
Nayar M.
67 
(1979) 411 93 22.6 273 66.5% 45 10.9 
Chitale A.R.
68 
(1987) 1222 300 24.6 642 52.5 280 22.9 
S.C. Peh 
69 
(1988) 209 - - 188 90 21 10 
Rao V.S.
70
(1994) 523 235 44.9 206 39.4 82 15.7 
Present study (2014) 90 53 58.9 33 36.7 4 4.4 
 
In the present study, benign tumours were most commonly encountered 
constituting 58.9% of all lesions. These findings were similar to Rao V.S.
70 
(44.9%).  
Malignant tumours were second most common (36.7%) similar to the 
observations by Rao V.S.
70
 (39.4%). 
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 2) The comparative distribution of benign tumours has been shown in 
Table 29. 
Table 29 - Comparative distribution of benign tumours 
Bone tumour 
Nayar M
67 
(1979) n = 93 
 
 
Rao V.S.
70 
(1994) n = 235 
Nidhi V 
73 
(2012) n = 154 
Present study 
(2014) n = 53 
No % No % No % No % 
Osteoid osteoma 3 4.9 15 6.4 5 3.3 4 7.51 
Osteoblastoma 1 1.1 2 0.8 5 3.3 1 1.9 
Osteochondroma 52 54.3 96 40.7 38 24.7 35 66 
Chondroma 9 9.6 6 2.6 19 12.2 1 1.9 
Chondroblastoma 8 8.6 13 5.6 5 3.3 0 0 
CMF 5 5.4 6 2.6 4 2.5 1 1.9 
Hemangioma 2 2.1 6 2.6 2 1.3 0 0 
Desmoplastic 
fibroma 
8 8.6 0 0 0 0 0 0 
Neurofibroma 5 5.4 0 0 0 0 0 0 
GCT 0 0 91 38.7 76 49.4 11 20.8 
Total 93 100 235 100 154 100 53 100 
 
The most common benign tumour encountered in the present study was 
osteochondroma (66%). This result matches with those of Nayar M. (54.3%) and 
Rao V.S.(40.7%).  
Giant cell tumour was the second most common benign tumour in the present 
study (20.8%) similar to Rao V.S. (38.7%). 
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 3) The comparative distribution of primary malignant bone tumours in 
different studies has been shown in Table 30. 
Table 30 - Comparative distribution of primary malignant bone tumours 
Bone tumour 
Dorfman HD
74 
(1994) 
 n = 2627 
 
Rao VS
70 
(1994) 
n = 206 
Katchy KC
75 
(2005) 
n = 76 
Present study  
(2014) 
n = 22 
No % No % No % No % 
Osteosarcoma 922 35.9 94 45.7 16 21 11 50 
Chondrosarcoma 677 25.8 35 17 6 7.9 2 9.1 
Ewing sarcoma 420 16 40 19.4 23 30.3 4 18.3 
Myeloma 0 0 12 5.8 19 25 2 9.1 
Lymphoma 0 0 13 6.3 5 6.5 1 4.5 
Angiosarcoma 36 1.4 1 0.4 0 0 0 0 
MFH 149 5.7 0 0 0 0 0 0 
Fibrosarcoma 0 0 7 3.4 0 0 0 0 
Undifferentiated 32 1.2 0 0 0 0 0 0 
Chordoma 221 8.4 4 12 3 3.9 1 4.5 
Adamantinoma 6 5.2 0 0 0 0 0 0 
Hemangiopericytoma 0 0 0 0 2 2.6 0 0 
Malignant GCT 0 0 0 0 0 0 1 4.5 
Sarcoma (not otherwise 
classified) 
0 0 0 0 1 1.3 0 0 
Total 2627 100 206 100 76 100 22 100 
 
Osteosarcoma was the most common malignancy encountered in the present 
study (50%). This finding is in concurrence with Dorfman H.D (35.9%) and Rao 
V.S (45.7%). 
The second most common malignancy in the present study was Ewing sarcoma 
(18.3%). A similar finding was reported by Rao V.S. (19.4%). 
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One case of malignancy in GCT was diagnosed. A 32 year male , with biopsy 
proven GCT,  presented with pain and swelling in the right humerus for 3 
months. He had been treated with curettage and plate fixation for GCT with 
fracture one year back. Radiology was suggestive of sarcomatous change. 
FNAC done on the lesion showed groups of malignant spindle   cells in a 
haemorrhagic background. Biopsy from the tumour showed features of 
telangiectatic osteosarcoma. Subsequently, amputation specimen of right upper 
limb was received. Even after extensive sampling, giant cell tumour - like areas 
were not seen.  
Hashimoto
76
 K et al reported a similar case of malignancy in Giant cell tumour 
of tibia. 
II. AGE DISTRIBUTION OF BONE LESIONS 
The youngest patient in this study was a 5 year old boy with osteochondroma of 
scapula and the oldest was a 70 year old lady with metastatic 
adenocarcinomatous deposits in the femur. 
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1)  The comparison of age distribution of bone lesions is shown in Table 31. 
Table 31- Comparison of age distribution of bone lesions 
Age Group 
Nayar M.
67
(1979) Present study (2014) 
Number % Number % 
1
st
 decade 58 14.1 9 10 
2
nd
 decade 155 37.7 41 45.6 
3
rd
 decade 94 22.9 11 12.2 
4
th
 decade 59 14.3 13 14.5 
5
th
 decade 23 5.6 2 2.2 
6
th
 decade 15 3.6 7 7.8 
7
th
 decade 7 1.8 6 6.6 
8
th
 decade 0 0 1 1.1 
Total 411 100 90 100 
 
Majority of patients in the present study were in their second decade of life 
(45.6%). This finding is similar to Nayar M.
67 
(1979) who reported 37.7% 
patients in the second decade. 
 The occurrence of bone tumours more commonly in the second decade of life 
probably suggests that adolescents and young adults are more susceptible to 
bone tumours due to local changes related to rapid growth of bones during 
adolescent growth spurt
71
. 
The age group commonly involved in osteosarcoma was second decade of life. 
In the present study, the average age of patients with metastatic bone tumour 
deposits was 53 years. This finding correlates well with Rhutso
77
 et al and 
Sirikulchayanonta
78
 et al  who reported an average age of 50 years. 
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 2) The comparison of distribution of bone tumours in the paediatric age 
group is shown in Table 32. 
Table 32 - Comparison of distribution of bone tumours in the paediatric age 
group (0 – 18 years) 
Bone lesions 
Hendrik van den Berg
72 
(2005) 
n = 1474 
Present study 
(2014) 
n = 46 Number % Number % 
ABC 101 6.9 1 2.2 
Adamantinoma 13 0.9 0 0 
Chondroblastoma 22 1.5 0 0 
CMF 9 0.6 0 0 
Chondroma 137 9.3 0 0 
Chondrosarcoma 7 0.5 0 0 
Ewing sarcoma 79 5.4 4 8.7 
Fibrous dysplasia 85 5.8 0 0 
Fibrous histiocytoma 2 0.1 0 0 
Fibrosarcoma 5 0.3 0 0 
Non-ossifying 
fibroma 
48 3.3 0 0 
Osteoblastoma 23 1.6 0 0 
Osteochondroma 655 44.4 28 60.9 
Osteosarcoma 126 8.5 8 17.4 
GCT 20 1.4 2 4.3 
Solitary bone cyst 54 3.7 0 0 
Osteoid osteoma 88 6.0 2 4.3 
Osteofibrous 
dysplasia 
0 0 1 2.2 
Total 1474 100 46 100 
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The most common benign tumour in the paediatric age group in the present 
study was osteochondroma  (60.9%)  which is similar to the findings by Hendrik 
van den Berg
72 
(2005).  
Osteosarcoma was the most frequently occurring primary malignancy in the 
paediatric age group (17.4%) in the present study. This is consistent with the 
findings of Hendrik van den Berg
72 
(2005). Ewing sarcoma was the second most 
common malignant tumour (8.7 %). 
III. GENDER DISTRIBUTION OF BONE TUMOURS 
 1) In the present study, the ratio of male to female patients with bone 
tumours and tumour – like lesions was 1.78:1. This male preponderance 
observed is similar to that reported by Baena – Ocampo Ldel C79. 
 2) Nearly 75% of all osteosarcomas in the present study occurred in 
males. This finding correlated well with the findings of Shah
80
 S.H. et al. 
 3) All four cases of osteoid osteoma in the present study were seen in 
males. This male preponderance seen for the tumour is similar to that reported 
by Panagotis
81
 et al (2:1 ratio). 
IV. DISTRIBUTION OF BONE TUMOURS BY SITE OF 
INVOLVEMENT 
 1) The most common site of occurrence of bone tumours in the present 
study was the femur (28.9%) followed by tibia (21.1%).  
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Thus, the majority of  bone tumours occurred around the knee joint.  Rhusto
77
 et 
al had similar findings with 30.6% tumours in femur and 29% in tibia. 
 2) Osteosarcoma showed a predilection for femur with 4 out of 11 cases  
(36.4%) occurring there.  Tibia was the next common site (27.3%). The findings 
are in concordance with Rhusto et al. 
 3). 63.6% of all giant cell tumours occurred in the tibia in the present 
study. Similar preponderance for tibia was noted by Karun Jain
2
 et al. There 
were two cases of recurrent giant cell tumours in this study. One was a 35 year 
female with recurrent GCT in the distal end of radius after 6 months of initial 
treatment with curettage. The second case was of a 37 year old male with 
recurrence of GCT in the proximal tibia after one year of treatment. Resection of 
proximal tibia with arthrodesis was the treatment given to him. 
 4). Small bone (metacarpal and phalanx) were involved in 4.4% cases. 
There was a case of GCT of 4
th
 metacarpal of left hand in a 17 year male treated 
with ray amputation. Another case was of an enchondroma of third metacarpal 
of the left hand in a 21 year old female. 
 5). Flat bones along with sacrum and spine were involved in 17.7% of the 
cases. There were three cases of osteochondroma in the scapula and one case of 
chondrosarcoma. 
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 6). Out of the 11 cases of metastatic deposits, 4 were found in the femur 
comprising 36.4% of the cases. Humerus was involved in 3 cases, sternum in 2 
and skull and spine in one case each. Thus, femur was the most common bone 
with metastatic deposits in the present study. This result is in agreement with 
Karun Jain
2
. Axial skeleton was involved in 36.3% of all metastatic deposits. 
V. CLINICORADIOLOGICAL AND HISTOPATHOLOGICAL 
AGREEMENT IN DIAGNOSIS OF BONE TUMOURS AND TUMOUR – 
LIKE LESIONS 
Considering all bone lesions together, clinico - radiological diagnosis was 
confirmed by similar histopathological diagnosis in 85 out of the 90 cases 
(94.44%).  
The histopathological diagnosis was not in agreement with clinico – radiological 
diagnosis in 5 out of the total of 90 cases. 
The corresponding Cohen’s Kappa value calculated was 0.943. This showed 
excellent agreement between clinico – radiological and histopathological 
diagnosis of  bone tumours and tumour – like lesions in this study. 
Comparison of Cohen’s Kappa value has been shown in Table 33. 
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Table 33 - Comparison of Cohen’s Kappa value 
Study 
No. of 
cases 
No of cases 
with 
disagreement 
Agreement 
percentage 
Cohen’s 
kappa 
value 
Interpretation 
of Kappa 
value 
Negash
3
 et 
al (2009) 
205 33 83.90% 0.82 Excellent 
agreement 
Present 
study(2014) 
90 5 94.44% 0.94 Excellent 
agreement 
 
Thus, the agreement between clinico – radiological and histopathological 
diagnosis was similar to the study by Negash et al. 
The 5 cases in the present study where clinico – radiological diagnosis and 
histopathological diagnosis were not in agreement were –  
 1) A 60 year male presented with swelling and pain in the proximal part 
of left upper limb for one year. MRI revealed a large expansile lesion over the  
left humerus in the meta – diaphysis extending to epiphysis. Cortical destruction 
and pathological fracture were noted. A clinico – radiological diagnosis of 
lymphoma was offered. The biopsy received in our department showed sheets of 
plasma cells with many binucleate forms. IHC by CD 138 marker showed strong 
membrane positivity. A diagnosis of plasma cell myeloma was offered and 
further biochemical investigations were suggested. 
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A similar case was reported by Ajit Mahale
82
 et al where a  lytic lesion of skull 
base with radiological differential diagnoses of lymphoma and plasmacytoma 
was finally reported as plasmacytoma by histopathological examination. 
Ly JQ
83
 et al also reported a case of plasmacytoma of proximal humerus in 
2005. 
 2) A 45 year male presented with swelling and pain  in the right side of 
hip for past 6 months. MRI pelvis showed an expansile bone lesion in the right 
iliac blade with bone destruction.  
A clinico – radiological diagnosis of plasmacytoma was offered. 
Histopathological examination of the biopsy revealed polymorphic tumour cells  
with vesicular nucleus arranged in sheets. IHC marker analysis showed strong 
positivity of tumour cells for CD 45. As the patient had no evidence of disease 
elsewhere in the body, a final diagnosis of primary lymphoma of bone was 
made. 
 3) A 14 year old male presented with pain and swelling in left side of hip 
for past 3 months. MRI revealed a permeative lytic lesion of left iliac wing and a 
clinico – radiological diagnosis of Ewing sarcoma was made. However 
histopathology showed malignant sarcoma cells producing osteoid. A diagnosis 
of Osteosarcoma was made. Unni
85
 K.K. reported that radiating spicules from 
the cortex of an affected bone may cause difficulty in differentiation of Ewing 
sarcoma from osteosarcoma especially in a flat bone like ilium. 
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 4) 35 year patient with history of tuberculosis on treatment presented with 
sudden onset of backpain and difficulty in walking for one week. MRI showed 
bone and disc destruction at D7 – D8 level. A clinico – radiological diagnosis of 
tubercular spondylolisthesis was made. The biopsy material received showed 
sheets of plasma cells with many binucleate forms. A final diagnosis of 
plasmacytoma was made and further investigation was suggested. 
 5) 17 year old male patient presented with swelling and pain over dorsum 
of left hand for 3 months. X ray and MRI revealed an osteolytic lesion involving 
the left 4
th
 metacarpal with soft tissue extension. A clinico – radiological 
diagnosis of enchondroma was made. FNAC showed a double population of 
cells – mononuclear spindle cells and osteoclastic giant cells attached to the 
periphery of the spindle cell clusters. A provisional diagnosis of GCT was made 
which was confirmed by histopathology. Ray amputation was done as GCT of 
small bones has a high rate of recurrence. 
Mohammad Shahid
84
 et al reported a similar case where GCT of metacarpal was 
diagnosed as enchondroma by radiology. 
The incidence of giant cell tumours in small bones is very less. Unni
85
 et al 
reported an incidence of 1% and Averill
86
 et al reported an incidence of 1.5% in 
their studies. 
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 There is very good agreement between clinico – radiological and 
histopathological diagnosis in bone tumours and tumour – like lesions. 
However, discrepancies do exist and an integrated approach involving clinical, 
radiological and histopathological examination is the gold standard to diagnose 
bone lesions. 
VI. FINE NEEDLE ASPIRATION CYTOLOGY OF BONE TUMOURS 
 FNAC was performed in 15 cases with clinico – radiological suspicion of 
bone tumours. The clinical details and radiological findings were reviewed. 
  The most common diagnosis was giant cell tumour which was diagnosed 
correctly in all 5 cases with suspicion of GCT.  Rana Sherwani
87
 et al also 
reported GCT to be the most common diagnosis by FNAC in their study. 
 The most common malignant tumour in our study to be diagnosed by 
FNAC was osteosarcoma. In 5 cases with clinico – radiological suspicion of 
osteosarcoma, a categorical diagnosis of osteosarcoma was made based on 
sarcomatous cells and pink amorphous intercellular material consistent with 
osteoid in 3 cases (60%). This finding is similar to that reported by Wahane
87
 et 
al (63.6%). However, in 2 cases only malignant sarcomatous cells were seen 
without osteoid. Hence, they were diagnosed as sarcoma, not otherwise 
specified. Histopathological analysis of biopsy however was diagnostic of 
osteosarcoma.  
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 A 32 year old patient with history of breast cancer treated 2 years back 
had presented with swelling in the costochondral junction and FNAC revealed 
malignant tumour cells arranged in ductal pattern. A diagnosis of metastatic 
deposits was made. 
 A 60 year old man with a clinico – radiological diagnosis of lymphoma of 
humerus was diagnosed as plasma cell lesion by FNAC showing scattered 
plasma cells with few a binucleate forms. The finding was later confirmed by 
histopathology. 
 Out of the 15 cases, 3 samples were inadequate for evaluation. This 
constituted 20 % of the cases. Handa
89
 et al reported a similar percentage of 
inadequacy (18.2 %). 
Sudipta
90
et al reported a very low percentage of inadequate samples (13.7%) and 
attributed it to repeated attempt of aspiration in difficult cases. They also 
recommended clinico - radiological correlation to determine the suitable area for 
aspiration. 
Excluding the cases with inadequate sampling, in the present study accurate 
diagnosis could be given in 10 out of the 12 cases by FNAC (83.3%). 
In this era of neoadjuvant chemotherapy and limb salvage surgeries, FNAC can 
prove to be of great value in diagnosing bone tumours. This is especially true 
when FNAC diagnosis correlates with clinico – radiological diagnosis.  
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It can be a cost effective tool obviating the need for open biopsies. However, in 
cases where cytopathological diagnosis is debatable and not in concurrence with 
radiology, FNAC cannot substitute histopathological examination. 
VII. BONE TUMOUR DIAGNOSIS – THE ROLE OF IHC 
In the present study, there were two cases where IHC helped in confirming the 
histopathological findings. 
 1). A 50 year female presented to the neurosurgery department with 
history of swelling in the right side of head and headache for 2 months. MRI 
revealed a large mass in the right parietal lobe with destruction of the overlying 
skull bone. A clinico – radiological diagnosis of metastatic deposit involving 
skull and brain was made. There was no evidence of primary tumour anywhere. 
Biopsy received showed tumour cells arranged  in follicular pattern invading the 
skull bone and brain parenchyma. At places eosinophilic material resembling 
colloid was seen. A diagnosis of metastatic deposits was made with a suggestion 
of primary tumour in thyroid - follicular carcinoma thyroid. IHC analysis 
revealed malignant follicular cells showing strong nuclear positivity for TTF - 1 
(Thyroid transcription factor – 1). Colloid stained strongly with thyroglobulin. 
On closer examination of the thyroid by ultrasonogram, a small nodule in the 
thyroid was found which on histopathology showed follicular carcinoma 
thyroid. 
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2). The second case was a 45 year old male with tumour of right iliac blade and 
clinico – radiological diagnosis of plasmacytoma. However, the provisional 
histopathological diagnosis of lymphoma was confirmed by IHC with CD 45 
marker. 
IHC is used in bone tumours mainly to differentiate primary tumour from 
metastatic deposits and to diagnose the primary tumour in case of occult 
primary. The role of IHC in bone tumours has been discussed by Gao
5
 et al and 
Ushigome
91
 et al. Categorisation of small round cell tumours where 
histopathology is not confirmative, is also an area where IHC plays a major role.  
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SUMMARY 
In the present prospective study of 90 bone tumours and tumour – like lesions 
evaluated by histopathological examination, Fine Needle Aspiration Cytology 
and immunohistochemistry, the following results were obtained,  
• Bone tumours and tumour - like lesions constituted only 1.03 % of all 
diagnosed neoplasms during the study period. 
• Out of the 90 cases, 86 cases (95.6%) were bone tumours and only 4 cases 
(4.4%) were tumour-like lesions. 
• 53 cases (58.9%) were benign tumours and 33 cases (36.7%) were 
malignant tumours. 
• Among the malignant tumours, 22 cases (66.7%) were primary 
malignancies of the bone and 11 cases (33.3%) were metastatic deposits. 
• Cartilage tumours were the most common constituting 43.3% followed by 
osteogenic tumours 17.8%. Giant cell tumours and metastatic 
malignancies constituted 12.2% each. 
• Osteochondroma was the most frequently encountered benign tumour 
constituting 66% followed by Giant cell tumour 20.8%. 
• Among the primary malignant tumours of bone, osteosarcoma was the 
most      common (50%) followed by Ewing sarcoma (18.3%). Plasma cell 
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myeloma and chondrosarcoma constituted 9.7 % each. There was one 
case each of malignancy in GCT, chordoma and malignant lymphoma. 
• Commonest presenting symptom was swelling (63.3%) followed by pain  
  and swelling (13.4%). 
• The incidence of bone tumours was maximum in second decade of life 
(45.6%). 
• 51.1% cases were in the paediatric age group (0-18 years).  
• Osteochondroma was the most common benign bone tumour in paediatric  
age group also (60.9%). 
• Osteosarcoma was the most common malignant tumour in the paediatric   
age group (17.4%) followed by Ewing sarcoma (8.7%). 
• Bone tumours commonly occurred around the knee joint (23.3%). 
• The most common site for bone tumours was the femur (28.9%) followed  
by tibia (21.1%). 
• Involvement of the axial skeleton occurred in 13.3% of the cases. 
• Small bone involvement was seen in 4.4% of the cases. 
• Osteochondromas occurred in the humerus most commonly (28.6%). 
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• Osteosarcomas occurred commonly in the distal femur (36.4%) followed     
           by proximal tibia (27.3%) . 
• Tibia was the bone most commonly involved by giant cell tumour (63.6). 
• Femur was the commonest site of metastatic deposits (36.4%). 
• 27.2% of metastatic deposits occurred in the humerus. 
• Flat bones including sacrum and spine were the site of metastatic deposits 
in 17.7% of the cases. 
• The average age of patients with metastatic deposits was 53 years. 
• Aneurysmal bone cyst was the commonest tumour – like lesion (75%). 
• Osteosarcomas (75%) and osteoid osteomas (100%) showed male 
preponderance. 
• Metaphysis was the commonest site involved by bone tumours (48.9%). 
• The commonest radiological picture of bone tumours among lytic lesions 
was of a lytic and poorly defined lesion (20%). 
• 85 cases showed agreement between clinico – radiological and 
histopathological diagnosis. Only 5 cases were in disagreement. The 
corresponding Cohen’s Kappa value was 0.943 which showed excellent 
agreement between clinico – radiological and histopathological diagnosis. 
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• FNAC was done in 15 cases of bone tumours out of which three smears 
were inadequate. 
• GCT was the commonest diagnosis given by FNAC (33.3%). 
• Categorical diagnosis was correctly rendered in 10 out of 12 cases 
(83.3%) in which smears were adequate for evaluation. 
• Immunohistochemistry was useful in confirming a diagnosis of primary 
malignant lymphoma of bone and a case of metastatic skull deposits of 
follicular carcinoma thyroid with occult primary. 
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CONCLUSION 
Histological examination of bone tumours is considered to be a challenging field 
in pathology. Bone tumours and tumour – like lesions are very rare. The low 
incidence of these tumours and the resulting limited experience in dealing with 
them adds to the diagnostic difficulties. 
 Clinico – radiological evaluation of bone tumours and tumour – like lesions is 
an essential part of patient management. Histopathological diagnosis should be 
given after proper review of clinical and radiological findings.  
There is very good agreement between clinico – radiological and 
histopathological diagnosis in bone tumours. However, many benign bone 
tumours and tumour - like lesions mimic malignant lesions radiologically. 
Hence, histopathological confirmation of radiological diagnosis should be 
always done before definitive treatment. 
A close co – ordination between the orthopaedician, radiologist and pathologist 
is the best approach to treat a patient with bone tumours. 
In this era of neoadjuvant chemotherapy and limb salvage surgeries, Fine Needle 
Aspiration Cytology can serve as a good tool for rendering quick and cost 
effective diagnosis for further management. However, the results of FNAC 
should be cautiously interpreted and when in doubt, histopathological 
confirmation should be obtained before treatment.  
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Immunohistochemistry has its own valuable role in bone tumour diagnosis. It 
can be a valuable tool in categorising small round cell tumours and determining 
sites of occult primary in case of metastasis to bone. 
Neoplasms of bone are being studied with several new modalities including flow 
cytometry and cytogenetics
85
. These techniques may prove to be very important 
in future especially in predicting response to treatment. 
 
 
 
 
 
ANNEXURE - I 
WHO HISTOLOGICAL CLASSIFICATION OF BONE TUMOURS 
(2002) 
CARTILAGE TUMOURS OSTEOGENIC TUMOURS 
OSTEOCHONDROMA OSTEOID OSTEOMA 
CHONDROMA OSTEOBLASTOMA 
   ENCHONDROMA OSTEOSARCOMA 
   PERIOSTEAL CHONDROMA    CONVENTIONAL 
   MULTIPLE CHONDROMATOSIS          CHONDROBLASTIC 
CHONDROBLASTOMA          FIBROBLASTIC 
CHONDROMYXOID FIBROMA          OSTEOBLASTIC 
CHONDROSARCOMA    TELANGIECTATIC 
   CENTRAL, PRIMARY, SECONDARY    SMALL CELL 
   PERIPHERAL    LOW GRADE CENTRAL 
   DEDIFFERENTIATED    SECONDARY 
   MESENCHYMAL    PAROSTEAL 
   CLEAR CELL    PERIOSTEAL 
FIBROGENIC TUMOURS    HIGH GRADE SURFACE 
DESMOLASTIC FIBROMA  EWING SARCOMA/PRIMITIVE 
NEUROECTODERMAL TUMOUR FIBROSARCOMA 
FIBROHISTIOCYTIC TUMOURS EWING SARCOMA 
BENIGN FIBROUS HISTIOCYTOMA NOTOCHORDAL TUMOURS  
MALIGNANT FIBROUS HISTIOCYTOMA CHORDOMA 
 
 
 
HEMATOPOIETIC TUMOURS NEURAL TUMOURS  
PLASMA CELL MYELOMA NEURILEMMOMA 
MALIGNANT LYMPHOMA, NOS MISCELLANEOUS TUMOURS 
GIANT CELL TUMOUR ADAMANTINOMA 
GIANT CELL TUMOUR METASTATIC MALIGNANCY 
MALIGNANCY IN GCT MISCELLANEOUS LESIONS 
VASCULAR TUMOURS ANEURYSMAL BONE CYST 
HEMANGIOMA SIMPLE CYST 
ANGIOSARCOMA FIBROUS DYSPLASIA 
SMOOTH MUSCLE TUMOURS OSTEOFIBROUS DYSPLASIA 
LEIOMYOMA LANGERHANS CELL HISTIOCYTOSIS 
LEIOMYOSARCOMA ERDHEIM – CHESTER DISEASE 
LIPOGENIC TUMOURS CHEST WALL HAMARTOMA 
LIPOMA JOINT LESIONS 
LIPOSARCOMA SYNOVIAL CHONDROMATOSIS 
 
 
 
 
 
 
ANNEXURE - II 
PROFORMA 
A STUDY OF AGREEMENT BETWEEN CLINICORADIOLOGICAL AND 
HISTOPATHOLOGICAL  DIAGNOSIS OF BONE TUMOURS AND TUMOUR- 
LIKE LESIONS WITH FNAC STUDY IN SELECTED CASES 
 
1. Name  
2. Age  
3. Sex  
4. Ip/Op number 
5. Occupation 
6. Address 
7. Phone number  
8. Socioeconomic status 
9.  Presenting complaints 
10. H/o presenting complaints 
 
 
11. Past history/ Personal history 
12. Family history 
13. General physical examination  
14. Systemic examination 
  CVS 
  RS 
  Per abdomen 
  CNS 
15. Lymph nodes 
16. Local examination 
17.  Investigations: Hb %  TC  DC    ESR 
18. Relevant Biochemical findings 
 
 
19. Radiological Findings  
  X RAY 
  MRI 
  CT  
 
 o Location – epiphysis, metaphysis, diaphysis, apophysis 
 o Location – centric, eccentric , juxtacortical 
 o Periosteal reaction 
 o Cortical destruction 
 o Matrix 
 o Monostotic or polyostotic 
 o Soft tissue extension 
 o Any other comments 
 
 
CLINICO - RADIOLOGICAL IMPRESSION 
 
 
 
20. Grossing notes      Biopsy number 
 o Type of specimen – biopsy/ curettage, resection, amputation 
 o Tumour site – epiphysis, metaphysis , diaphysis, apophysis, medullary cavity, 
  joint involvement, soft tissue extension 
 o Tumour size 
 o External surface appearance 
 o Cut surface appearance 
21.  Microscopic examination 
   
   
    
 
   HISTOPATHOLOGICAL IMPRESSION 
 
 
22. FNAC diagnosis  
 
 
ANCILLARY INVESTIGATIONS 
 
23. IHC 
 
 
 
FINAL DIAGNOSIS 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE – III 
 
Haematoxylin and Eosin staining method 
 
1. Sections were dewaxed with xylene for 20 minutes.  
2. Sections were hydrated through descending concentrations (absolute alcohol,   
90%, 70%, 50%) of ethanol to water solutions.  
3. Sections were rinsed in distilled water.  
4. Sections were placed in Ehrlich haematoxylin stain for 20-30 minutes.  
5. Sections were rinsed with water.  
6. Differentiation was done by immersing the sections in 1% acid alcohol for            
10 seconds.  
7. Sections were rinsed with water.  
8. Blueing was done by keeping the sections in scott’s tap water for 2-10 
minutes.  
9. Counterstaining was done with 1% aqueous eosin for 1-3 minutes.  
10. Sections were rinsed with water.  
11. Sections were dehydrated through increasing concentrations of ethanol 
solutions (50%,70%, 95%, absolute alcohol) and cleared with xylene.  
12. Sections were mounted with DPX . 
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ANNEXURE - V 
KEY TO MASTER CHART 
 
GENDER 
Male – M 
Female – F 
 
COMPLAINTS 
Swelling – 1 
Pain – 2 
Swelling and pain – 3 
Fracture – 4 
Constipation – 5 
Pain and difficulty in walking – 6 
 
NUMBER OF SWELLINGS 
Single – 1 
Multiple – 2 
 
LATERALITY 
Right – R 
Left – L 
 
SITE  
Apophysis – 1 
Diaphysis – 2 
Epi – metaphysis – 3 
Epiphysis – 4 
Flat bone – 5 
Meta - diaphysis – 6 
Metaphysis – 7 
 
BONE  
Proximal femur – 1 
Shaft of femur – 2 
Distal femur – 3 
Proximal fibula – 4 
Distal fibula – 5 
Proximal humerus – 6 
Shaft of humerus – 7 
Ilium – 8 
Metacarpal – 9 
Phalanx – 10 
Distal radius – 11 
Sacrum – 12 
Scapula – 13 
Skull – 14 
Spine – 15 
Sternum – 16 
Proximal tibia – 17 
Shaft of tibia – 18 
Distal tibia – 19 
Ulna – 20 
 
 
MACROSCOPY 
Amputation – 1 
Biopsy – 2 
Curettage – 3 
Resection – 4 
 
RADIOLOGICAL FINDINGS 
Lytic lesion with rim of sclerosis – 1 
Lytic lesion with well – defined margins – 2 
Lytic lesion with ill – defined margins – 3 
Permeative lytic lesion – 4 
Sclerotic lesion – 5 
Lytic and sclerotic lesion – 6 
Lytic lesion with specks of calcification – 7 
Pedunculated or sessile lesion with cartilage cap; cortex and marrow in 
continuity with bone of origin - 8 
 
CLINICO – RADIOLOGICAL DIAGNOSIS / HISTOPATHOLOGICAL 
DIAGNOSIS/ FNAC DIAGNOSIS 
ABC – 1 
Chondromyxoid fibroma – 2 
Chondrosarcoma – 3 
Chordoma – 4 
Enchondroma – 5 
Ewing Sarcoma – 6 
GCT – 7 
Malignant GCT – 8 
Malignant Lymphoma – 9 
Metastatic deposits – 10 
Metastatic Adenocarcinoma deposits – 10A 
Metastatic Squamous cell carcinoma deposits – 10B 
Metastatic Thyroid carcinoma deposits – 10C 
Osteoblastoma – 11 
Osteochondroma – 12 
Osteofibrous Dysplasia – 13 
Osteoid osteoma – 14 
Osteosarcoma – 15 
Plasmacytoma – 16 
Pott’s Spine – 17 
Recurrent GCT - 18 
Sarcoma, not otherwise specified – 19 
Inadequate for evaluation - 20 
 
NA – Not Applicable 
HPE NO – Histopathological Examination Number 
Histopath – Histopathological 
 
 
 
 
 
 
 
ANNEXURE – VI A :   MASTER CHART 
S.NO AGE SEX 
IP/OP 
NO COMPLAINTS 
NO OF 
SWELLINGS LATERALITY SITE BONE MACROSCOPY 
RADIOLOGICAL 
FINDINGS 
CLINICO - 
RADIOLOGICAL 
DIAGNOSIS HPE NO 
HISTOPATH 
DIAGNOSIS 
1 17 F 4441 1 2 R 7 3 4 8 12 229/12 12 
2 10 M 6031 1 1 R 7 10 4 8 12 271/12 12 
3 13 F 26754 1 1 L 7 3 4 8 12 439/12 12 
4 70 M 4319 4 NA L 2 3 2 6 10 579/12 10A 
5 12 M 11274 1 1 L 7 4 4 8 12 621/12 12 
6 7 F 9241 3 1 R 7 17 2 6 15 669/12 15 
7 11 F 9526 1 1 R 7 6 4 8 12 722/12 12 
8 15 M 18742 3 1 L 7 3 2 6 15 1082/12 15 
9 52 M 20571 4 NA R 2 7 2 6 10 1202/12 10A 
10 10 M 23456 1 1 R 7 3 4 8 12 1283/12 12 
11 12 F 26778 1 1 L 7 17 4 8 12 1527/12 12 
12 15 M 32136 1 1 R 7 6 4 8 12 1716/12 12 
13 18 M 32544 1 1 L 7 4 2 6 15 1721/12 15 
14 23 M 26944 1 1 R 7 1 4 8 12 1758/12 12 
15 8 M 33682 1 2 L 7 17 4 8 12 1779/12 12 
16 10 M 51 1 1 L 7 6 4 8 12 1866/12 12 
17 18 M 32195 1 1 R 3 17 2 3 7 1875/12 7 
18 8 M 54 1 1 R 7 6 4 8 12 1920/12 12 
19 25 M 8912 1 1 R 7 6 4 8 12 1928/12 12 
20 9 M 36151 1 1 L 7 11 4 8 12 2039/12 12 
21 18 M 562 1 1 L 7 3 4 8 12 2045/12 12 
22 16 M 38070 1 1 R 7 6 4 8 12 2148/12 12 
23 9 M 86 1 1 R 7 6 4 8 12 2253/12 12 
24 40 M 57321 1 1 R 4 17 2 3 7 2306/12 7 
25 15 M 25345 1 1 R 7 3 4 8 12 2321/12 12 
26 15 F 52843 1 1 L 6 1 2 4 6 3030/12 6 
27 12 F 124 1 1 L 7 3 4 8 12 3131/12 12 
28 19 M 189 1 1 L 7 17 4 8 12 3374/12 12 
29 30 M 569770 2 NA L 2 2 4 5 14 3585/12 14 
 
S.NO AGE SEX IP/OP NO COMPLAINTS 
NO OF 
SWELLINGS LATERALITY SITE BONE MACROSCOPY 
RADIOLOGICAL 
FINDINGS 
CLINICO - 
RADIOLOGICAL 
DIAGNOSIS HPE NO 
HISTOPATH 
DIAGNOSIS 
30 35 F 197 1 1 R 4 11 3 3 7 3645/12 7 
31 65 F 74733 3 1 R 6 10 4 7 3 3954/12 3 
32 30 M 72183 2 NA L 3 3 3 1 1 4083/12 1 
33 14 M 68156 1 1 R 2 2 2 4 6 4199/12 6 
34 13 F 673974 3 1 R 7 17 1 6 15 4202/12 15 
35 14 F 97098 1 2 R 7 6 4 8 12 22/13 12 
36 15 M 52 2 NA NA 5 15 4 5 14 343/13 14 
37 55 F 53 5 NA NA 5 12 2 3 4 480/13 4 
38 32 F 71008 1 1 R 5 16 2 3 10 495/13 10A 
39 60 M 8680 4 NA L 2 7 2 3 10 705/13 10B 
40 39 F 10783 4 NA R 2 2 2 3 10 819/13 10A 
41 15 M 119 3 1 R 7 3 1 6 15  1221/13 15 
42 59 F 18363 2 NA NA 5 15 2 3 10 1267/13 10C 
43 50 F 14641 2 NA NA 5 14 2 3 10 1321/13 10C 
44 60 F 20528 3 NA NA 5 16 2 3 10 1370/13 10B 
45 16 M 13840 1 1 L 7 4 4 8 12 1569/13 12 
46 13 M 31163 1 1 R 5 8 4 8 12 1839/13 12 
47 37 M 242 1 1 L 6 17 4 3 7 1925/13 7 
48 9 M 57200625 1 1 R 7 17 4 8 12 2033/13 12 
49 11 F 321 1 1 R 7 5 4 1 1 2035/13 1 
50 32 M 326 1 1 R 6 6 1 3 8 2206/13 8 
51 38  M  116 2 NA L 7 17 4 5 14 2349/13 14 
52 17 M 41704 1 1 L 7 11 2 6 15 2472/13 15 
53 30 F 414 2 NA R 7 1 2 2 2 2637/13 2 
54 50 M 387 1 1 R 7 3 2 6 15 2875/13 15 
55 18 M 441 1 1 L 5 8 4 8 12 2962/13 12 
56 6 F 395 4 NA L 2 1 2 4 6 3008/13 6 
57 17 M 471 3 1 R 7 17 2 6 15 3018/13 15 
58 19 M 43543 1 2 L 7 17 4 8 12 3031/13 12 
59 16 M 53114 1 1 R 5 8 2 4 6 3231/13 6 
 
S.NO AGE SEX 
IP/OP 
NO COMPLAINTS 
NO OF 
SWELLINGS LATERALITY SITE BONE MACROSCOPY 
RADIOLOGICAL 
FINDINGS 
CLINICO - 
RADIOLOGICAL 
DIAGNOSIS HPE NO 
HISTOPATH 
DIAGNOSIS 
60 65 M 18251 1 1 L 7 17 4 8 12 3286/13 12 
61 17 M 24755 1 1 L 5 13 4 8 12 3544/13 12 
62 35 F 4467 6 NA NA 5 15 2 3 17 4061/13 16 
63 17 M 678 1 1 L 3 9 1 3 5 4552/13 7 
64 37 M 744 1 1 L 4 19 2 2 7 4673/13 7 
65 19 M 43762 1 1 L 7 1 3 2 11 5048/13 11 
66 21 F 821 3 1 L 6 9 4 2 5 5068/13 5 
67 26 M 86934 2 NA L 1 1 2 1 1 5249/13 1 
68 60 M 805 3 1 L 6 6 2 3 9 5408/13 16 
69 60 F 87193 4 NA L 2 2 2 3 10 007/14 10B 
70 15 M 62 1 1 R 7 11 4 8 12 152/14 12 
71 45 M 845 1 1 R 5 8 2 3 16 186/14 9 
72 28 M 21 1 1 L 4 20 2 2 7 471/14 7 
73 25 M 55 1 2 R 7 6 4 8 12 808/14 12 
74 23 F 4873 1 1 R 7 3 4 8 12 829/14 12 
75 18 F 3205 2 NA L 6 17 2 2 13 1668/14 13 
76 50 F 2441 4 NA L 2 2 2 3 10 1726/14 10B 
77 20 F 3391 4 NA R 7 3 2 6 15 1732/14 15 
78 14 M 3587 3 1 L 5 8 2 4 6 1830/14 15 
79 11 M 3948 1 1 R 7 6 4 8 12 1837/14 12 
80 24 F 2909 1 1 L 4 3 3 2 7 1978/14 7 
81 5 M 3596 1 1 L 5 13 4 8 12 1986/14 12 
82 6 M 3558 2 NA L 2 18 4 1 14 1995/14 14 
83 15 M 28932 1 1 L 7 3 4 8 12 2226/14 12 
84 12 M 2546 1 1 R 5 13 4 8 12 2272/14 12 
85 20 M 4223 1 1 R 4 17 3 2 7 2283/14 7 
86 19 F 12981 1 1 L 3 17 2 2 7 2506/14 7 
87 31 F 41187 3 1 R 5 13 4 7 3 2903/14 3 
88 33 F 8984 1 1 L 4 17 2 2 7 3080/14 7 
89 50 F 7562 4 NA L 6 6 2 6 10 3144/14 10A 
90 20 M 9410 3 1 L 7 6 2 6 15 3177/14 15 
 
ANNEXURE VI B – MASTER CHART FOR FNAC CASES 
S.NO  
AGE 
IN 
YRS 
SEX IP/OP 
NO. 
COMPLAINTS LATERALITY SITE  BONE  CLINICO - 
RADIOLOGICAL 
DIAGNOSIS 
HPE NO HISTOPATH 
DIAGNOSIS 
FNAC NO FNAC 
DIAGNOSIS 
1 7 F 9241 3 R 7 17 15 669/12 15 Cy 155/12 20 
2 13 F 673974 3 R 7 17 15 4202/12 15 Cy 952/12 19 
3 55 F 53 5 NA 5 12 4 480/13 4 Cy 154/13 20 
4 32 F 71008 1 R 5 16 10 495/13 10A Cy 230/13 10A 
5 15 M 119 3 R 7 3 15 1221/13 15 Cy 417/13 15 
6 37 M 242 1 L 6 17 7 1925/13 7 Cy 756/13 7 
7 18 M 32195 1 R 3 17 7 1875/12 7 Cy 985/12 7 
8 32 M 326 1 R 6 6 8 2206/13 8 Cy1065/13 19 
9 60 M 805 3 L 6 6 3 5408/13 16 Cy 1104/13 16 
10 17 M 41704 1 L 7 11 15 2472/13 15 Cy1159/13 15 
11 6 F 395 4 L 2 1 6 3008/13 6 Cy1284/13 20 
12 17 M 471 3 R 7 17 15 3018/13 15 Cy 1461/13 15 
13 17 M 678 1 L 3 9 7 4552/13 7 Cy 2043/13 7 
14 37 M 744 1 L 4 19 7 4673/13 7 Cy 2299/13 7 
15 28 M 21 1 L 4 20 7 471/14 7 Cy 2537/13 7 
 
ANNEXURE - VII 
LIST OF ABBREVIATIONS 
 
ABC   -   Aneurysmal Bone Cyst 
CT  -  Computed Tomography 
CVS  -  Cardiovascular System 
CMF  -  Chondromyxoid Fibroma 
CNS  -  Central Nervous System 
FNAC -  Fine Needle Aspiration Cytology 
GCT  -  Giant Cell Tumour 
H&E  -  Haematoxylin and Eosin 
IHC  -   Immunohistochemistry 
LCH  -  Langerhans Cell Histiocytosis 
MFH  -  Malignant Fibrous Histiocytoma 
NOF  -  Non Ossifying Fibroma 
MRI  -  Magnetic Resonance Imaging 
NHL  -  Non – Hodgkin Lymphoma 
PNET -  Primitive Neuroectodermal Tumour 
RS  -   Respiratory System 
WHO  -  World Health Organisation 
 
 
 
 
  
  
 
 
 
 
 
 
 
ANNEXURE -  VIII 
 
INSTITUTION ETHICAL COMMITTEE APPROVAL 
 
 
 
 
 
 


  
 
 
 
 
 
 
 
 
ANNEXURE – IX 
 
ANTI – PLAGIARISM CERTIFICATE 
 
 
 
 
 


